Document:

QuickLinks
 -- Click here to rapidly navigate through this document
  

 
 

Exhibit 10.25    
    

 
  EXHIBIT A
  
    PRODUCT AND SERVICE DESCRIPTION AND PRICING    
    

(Product Price listing is in Attachment 1 to Exhibit A, the Letter of Commitment is Attachment 2 to Exhibit A, and the Expense Cap Members in Attachment 3 to
Exhibit A)

	I.
	PRODUCT CATEGORIES:  

 Therapeutic Surfaces (Frameless—Mattress Replacement Systems)  

Low
Air Loss Therapy

Alternating Pressure Therapy

Pulsation Therapy

Lateral Rotation Therapy

Kinetic Therapy

Fluid Therapy

Other Related Products 

 Therapeutic Specialty Beds (integrated Framed Support Surfaces)  

Bariatric

Low Air Loss Therapy

Air fluidized Therapy

Pulsation Therapy

Lateral Rotation Therapy

Kinetic Therapy 

 Other Related Products/Devices  

Negative
pressure wound closure

Other products/devices

	II.
	PRICE STRUCTURE:  

        Members will be eligible for Product pricing based on the criteria listed below: 

	Tier
 
	 	Letter of

Commitment

Required
	 	Percent Utilization *

and **
	 	Annual

Purchase/Rental

Volume
	 	Notes

	Tier I—Base	 	No	 	None	 	N/A	 	 
	Tier II	 	Yes	 	[***]% wound care and pulmonary therapeutic Products, [***]% bariatric Products	 	$[***] - $[***]	 	 
	Tier III	 	Yes	 	[***]% wound care and pulmonary therapeutic Products, [***]% bariatric Products	 	$[***] - $[***]	 	 
	Tier IV	 	Yes	 	[***]% wound care and pulmonary therapeutic Products, [***]% bariatric Products	 	$[***] or greater	 	(1) Maximum of [***]% additional reduction over Tier III. Volume may be aggregated
	 	 	 	 	 	 	 	 	(2) Member facilities in a system can combine volume to meet requirements

1

 

*
BARIATRIC PRODUCT EXEMPTION: 

Supplier
will exclude from a Member's bariatric utilization measurement the purchase or rental of a competitive bariatric produce, which has a significant feature (as agreed to by Novation, Supplier
and Member) which is unavailable on a Supplier's bariatric product. This exemption shall no longer be operative if the Supplier develops and makes available a bariatric product with the feature
described above. 

**
TOTAL ANNUAL VOLUME REQUIREMENTS 

The
total annual dollar volume requirement will be calculated as follows:

-[***]% of the total wound care and pulmonary Product and competitive dollars purchased by the Member added with

-[***]% of the total bariatric Product and competitive dollars purchased by the Member 

	III.
	EXPENSE CAP MEMBERS:  

Members Currently Under Expense Cap Pricing:

Supplier
will grandfather all Members (list of Members in Attachment 3 to Exhibit A) participating in the Supplier's Expense cap pricing program. The Member will have the option of accessing
the Award Pricing under this agreement (after complying with all provisions of such Expense Cap program, including any termination fees or billing for non-charged therapy days) or maintain
its Expense Cap program. Marketing fees will be paid on Members participating in the supplier's Expense Cap program. 

Future Process for Members Requesting Expense Cap:  

Requirements
and process for requesting and receiving Expense Cap pricing: 

	1.
	Supplier
Field Sales Management and Novation Service Delivery Executive will conduct meeting with the Member's Chief Financial Officer and VP of Materials Management. 
	2.
	Annual
product rental volume must be greater than $[***] to be considered for the Expense Cap program 
	3.
	Expense
Cap will require Supplier's Senior Management approval. 
	4.
	Member
must commit to the Supplier's Positive Outcomes Wound Care Program and P&I Surveys with protocol review. 
	5.
	The
Member must agree to meet quarterly and assign a team leader for surface products. 
	6.
	The
expense Cap Program offered to Members shall be in accordance with the terms of Supplier's then-existing corporate Expense Cap Program, including the
then-existing Expense Cap pricing and terms.

	IV.
	PRICE PROTECTION  

Price Protection Terms: Award Prices will remain firm for the first three-years of the Agreement on all Products, except the V.A.C. and Dri-Flo Products which will
remain firm until August 31, 2002. Price increases for the fourth and fifth year of the Agreement shall be no greater than [***] ([***]%) per
year based on a weighted average of all Products. For the second through fifth year of the Agreement, the V.A.C. and Dri-Flo products shall be no greater than [***]
([***]%) per year based on a weighted average of all Products. The
Supplier must submit proposed Product pricing changes no later than 60 days prior to the price change effective date. 

	V.
	GRANDFATHERED PRICING  

Members will have until December 31, 2001 to sign up for the Award Prices in this Agreement. Members will be grand fathered in at their existing pricing until they
either sign a new Letter of Commitment or December 31, 2001. Members that have not signed a Letter of Commitment by December 31, 2001 may be placed on the Tier 1 Base Award Price 

2

  

 
 

Exhibit A-Line Item Award Pricing
  NOVATION L.L.C.
  KCI USA Inc.
  THERAPEUTIC SUPPORT SURFACES AND OVERLAYS
  LEVEL I PRICING—90% COMPLIANCE—COMMITTED DOLLAR VOLUME = $0-99,999    

	 
	 	PRODUCT

NUMBER
	 	DAILY RENTAL

LIST PRICE
	 	NON-

PARTICIPATING

DAILY RENTAL

PRICING
	 	SOLE SOURCE

DAILY RENTAL

PRICING LEVEL I
	 	DISCOUNT

OFF LIST

	WOUND CARE	 	 	 	 	 	 	 	 	 	 	 	 	 
	Air Fluidized Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	FluidAir® Elite	 	300500	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Therapeutic w/sit-up	 	300502	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	FluidAir® II	 	300680	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Air Cycle Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	InterCellTM	 	211660	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	>>Premium Service	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	>>Economy Service	 	 	 	 	 	 	$	[***]	 	$	[***]	 	[***]
	Fluid Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	RIK® Fluid Overlay	 	VL22000	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	RIK® Fluid Mattress	 	MA4000S/MA4200S	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Low Air Loss Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	KinAir® III	 	201001	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	KinAir® III w/o Scales	 	201260	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	KinAir® IV	 	226000	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	First Step® Select Overlay	 	203690	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	First Step® Plus	 	200600	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	First Step® Advantage	 	226500	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Pulsating Air Suspension Therapysm	 	 	 	 	 	 	 	 	 	 	 	 	 
	DynaPulse®	 	302150	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	TheraPulse®	 	9300	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	TheraPulse® II	 	9222	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	PULMONARY CARE	 	 	 	 	 	 	 	 	 	 	 	 	 
	Kinetic Therapysm	 	 	 	 	 	 	 	 	 	 	 	 	 
	Roto Rest® Delta	 	208030	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	TriaDyne® II	 	308550	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	ParaDyneTM	 	302720&302705	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	PediDyne®	 	204200-U	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Continuous Lateral Rotaton Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	TheraPulse® ATP	 	9222	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Q2 Plus®	 	200700	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]

Page 1

 
Exhibit A-Line Item Award Pricing

NOVATION L.L.C.

KCI USA Inc.

THERAPEUTIC SUPPORT SURFACES AND OVERLAYS

LEVEL I PRICING—90% COMPLIANCE—COMMITTED DOLLAR VOLUME = $0-99,999  

	 
	 	PRODUCT

NUMBER
	 	DAILY RENTAL

LIST PRICE
	 	NON-

PARTICIPATING

DAILY RENTAL

PRICING
	 	SOLE SOURCE

DAILY RENTAL

PRICING LEVEL I
	 	DISCOUNT

OFF LIST

	BARIATRIC CARE	 	 	 	 	 	 	 	 	 	 	 	 	 
	BariAirTM Therapy	 	310111	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariKare®	 	306000	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariMaxx	 	309300	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	First Step SelectTM HD	 	203800	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariAir Suite

(includes: BariAir, EZ lift,

Wheelchair, Walker,

Commode/Shower Chair)	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariKare Suite

(includes: BariKare, EZ lift,

Wheelchair, Walker,

Commode/Shower Chair)	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariMaxx Suite

(includes: BariMaxx, EZ lift,

Wheelchair, Walker,

Commode/Shower Chair)	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	EZ-Lift	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Bariatric Accessory Package

(includes: Wheelchair, Walker,

Commode)	 	820730930K-Kit	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]

Non-participating is defined as KCI USA not being primary vendor and bills less than 50% of available dollars. 

All
products are subject to availability. 

Page 2

 
Exhibit A-Line Item Award Pricing

NOVATION L.L.C.

KCI USA Inc.

THERAPEUTIC SUPPORT SURFACES AND OVERLAYS

LEVEL II PRICING—90% COMPLIANCE—COMMITTED DOLLAR VOLUME = $100,000+  

	 
	 	PRODUCT

NUMBER
	 	DAILY RENTAL

LIST PRICE
	 	NON-

PARTICIPATING

DAILY RENTAL

PRICING
	 	SOLE SOURCE

DAILY RENTAL

PRICING LEVEL II
	 	DISCOUNT

OFF LIST

	WOUND CARE	 	 	 	 	 	 	 	 	 	 	 	 	 
	Air Fluidized Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	FluidAir® Elite	 	300500	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Therapeutic w/sit-up	 	300502	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	FluidAir®	 	300680	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Air Cycle Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	InterCellTM	 	211660	 	$	[***]	 	 	 	 	 	 	 	 
	>>Premium Service	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	>>Economy Service	 	 	 	 	 	 	$	[***]	 	$	[***]	 	[***]
	Fluid Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	RIK® Fluid Overlay	 	VL22000	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	RIK® Fluid Mattress	 	MA4000S/MA4200S	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Low Air Loss Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	KinAir® III	 	201001	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	KinAir® III w/o Scales	 	201260	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	KinAir® IV	 	226000	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	First Step® Select Overlay	 	203690	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	First Step® Plus	 	200600	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	First Step® Advantage	 	226500	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Pulsating Air Suspension Therapytm	 	 	 	 	 	 	 	 	 	 	 	 	 
	DynaPulse®	 	302150	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	TheraPulse®	 	9300	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	TheraPulse® II	 	9222	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	PULMONARY CARE	 	 	 	 	 	 	 	 	 	 	 	 	 
	Kinetic Therapytm	 	 	 	 	 	 	 	 	 	 	 	 	 
	Roto Rest® Delta	 	208030	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	TriaDyne® II	 	308550	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	ParaDyneTM	 	302720&302705	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	PediDyne®	 	204200-U	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Continuous Lateral Rotaton Therapy	 	 	 	 	 	 	 	 	 	 	 	 	 
	TheraPulse® ATP	 	9222	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Q2 Plus®	 	200700	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]

Page 3

 
Exhibit A-Line Item Award Pricing

NOVATION L.L.C.

KCI USA Inc.

THERAPEUTIC SUPPORT SURFACES AND OVERLAYS

LEVEL II PRICING—90% COMPLIANCE—COMMITTED DOLLAR VOLUME = $100,000+  

	 
	 	PRODUCT

NUMBER
	 	DAILY RENTAL

LIST PRICE
	 	NON-

PARTICIPATING

DAILY RENTAL

PRICING
	 	SOLE SOURCE

DAILY RENTAL

PRICING LEVEL II
	 	DISCOUNT

OFF LIST

	BARIATRIC CARE	 	 	 	 	 	 	 	 	 	 	 	 	 
	BariAirTM Therapy	 	310111	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariKare®	 	306000	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariMaxx	 	309300	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	First Step SelectTM HD	 	203800	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariAir Suite

(includes: BariAir, EZ lift,

Wheelchair, Walker,

Commode/Shower Chair	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariKare Suite

(includes: BariKare, EZ lift,

Wheelchair, Walker,

Commode/Shower Chair	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	BariMaxx Suite

(includes: BariMaxx, EZ lift,

Wheelchair, Walker,

Commode/Shower Chair	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	EZ-Lift	 	 	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	Bariatric Accessory Package

(includes: Wheelchair,

Walker, Commode)	 	820730930K-Kit	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]

Non-participating is defined as KCI USA not being primary vendor and bills less than 50% of available dollars. 

All
products are subject to availability 

Page 4

 
EXHIBIT A-Line Item Award Pricing

NOVATION L.L.C.

KCI USA Inc.

The V.A.C.

RENTAL AND DISPOSABLE PRICING  

Equipment Rental

	Item
 
	 	DAILY RENTAL

LIST PRICE
	 	NON-

PARTICIPATING

DAILY RENTAL

PRICING
	 	SOLE SOURCE

CONTRACT

DISCOUNT
	 	SOLE SOURCE DAILY RENTAL PRICING

	The V.A.C.® Unit (8229514)	 	$	[***]	 	$	[***]	 	[***]	 	$	[***]
	Mini V.A.C.® (M6275732)	 	$	[***]	 	$	[***]	 	[***]	 	$	[***]

Disposable Sales

	Item
 
	 	Quantity
	 	11/1999

LIST PRICE
	 	SOLE SOURCE CONTRACT DISCOUNT
	 	SOLE SOURCE DAILY CONTRACT PRICING

	Small Dressing Kit (M6275001)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	Small Dressing Kit (M6275001-5)	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	Med. Dressing Kit (M6275002)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	Med. Dressing Kit (M6275002-5)	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	Large Dressing Kit (M6275003)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	Large Dressing Kit (M6275003-5)	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	Canister Kit w/o Iso (M6275007)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	Canister Kit w/o Iso (M6275007-5)	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	Canister Kit w/Iso (M6275008)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	Canister Kit w/Iso (M6275008-5)	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	V.A.C. ® Soft-Foam	 	 	 	 	 	 	 	 	 	 
	10x15cm assembly (M6275038)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	7.5x10cm assembly (M6275039)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	10x15cm w/o connector (M1202)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	2 way connector (M6275012)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	4 way connector (M6275015)	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	Mini Soft-Foam	 	 	 	 	 	 	 	 	 	 
	7.5x10cm assembly (M6275021)	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	Mini Polyurethane Foam (M6275037)	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	Mini Canisters (M6275022)	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	V.A.C.® extension tubing (M6275025)	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	DRAPES	 	10/carton	 	$	[***]	 	[***]	 	$	[***]
	V.A.C.® Hand Dressing	 	5/carton	 	$	[***]	 	[***]	 	$	[***]
	V.A.C.® Large Dressing	 	5/carton	 	$	[***]	 	[***]	 	$	[***]

V.A.C.® Discounts will be taken off list price at time of order. 

V.A.C.®
Rental Discounts will remain firm until January 1, 2001. 

V.A.C.®
volume is not factored into tiered pricing for Therapeutic Support Surfaces and Overlays. 

V.A.C.®
is not a committed program contracted product. 

DRIFLO®  

	PRODUCT
 
	 	QUANTITY
	 	LIST PRICE
	 	CONTRACT PRICE

	DriFlo®	 	Pkg of 12	 	$	[***]	 	$	[***]
	DriFlo®	 	Case of 6	 	$	[***]	 	$	[***]
	DriFlo® Extra Large	 	Case of 6	 	$	[***]	 	$	[***]

Page 5

 
Exhibit A-Line Item Award Pricing

NOVATION L.L.C.

KCI USA Inc.

Acute and LTC Purchase Pricing  

	 
	 	PRODUCT NUMBER
	 	STATUS
	 	LIST PRICE
	 	CONTRACT PRICE

	Wound Care	 	 	 	 	 	 	 	 	 	 
	Air Cycle Therapy	 	 	 	 	 	 	 	 	 	 
	IntercellTM	 	211660	 	New	 	$	[***]	 	$	[***]
	Low Air Loss Therapy	 	 	 	 	 	 	 	 	 	 
	KinAir® III	 	201001	 	New	 	$	[***]	 	$	[***]
	KinAir® III	 	201260	 	Remfg	 	$	[***]	 	$	[***]
	KinAir® III w/o	 	KA3KNO	 	Remfg	 	$	[***]	 	$	[***]
	KinAir® IV	 	226000	 	New	 	$	[***]	 	$	[***]
	First Step® Select	 	203690	 	New	 	$	[***]	 	$	[***]
	First Step® Advantage	 	226500	 	New	 	$	[***]	 	$	[***]
	First Step® TriCell	 	212542	 	New	 	$	[***]	 	$	[***]
	First Step® TriCell	 	212500	 	New w 2 Sheets	 	$	[***]	 	$	[***]
	Pulsating Air Suspension Therapysm	 	 	 	 	 	 	 	 	 	 
	DynaPulse®	 	302150	 	New	 	$	[***]	 	$	[***]
	Thera Pulse®	 	930	 	Refmg	 	$	[***]	 	$	[***]
	TheraPulse® II	 	9222	 	New	 	$	[***]	 	$	[***]
	Fluid Therapy	 	 	 	 	 	 	 	 	 	 
	RIK® Fluid Overlay	 	VL22000	 	 	 	 	 	 	 	 
	 	QTY 1-3	 	 	 	New	 	$	[***]	 	$	[***]
	 	4-10	 	 	 	New	 	$	[***]	 	$	[***]
	 	11-20	 	 	 	New	 	$	[***]	 	$	[***]
	 	21+	 	 	 	New	 	$	[***]	 	$	[***]
	RIK® Fluid Mattress (4000,4200)	 	MA4000S/MA4200S	 	 	 	 	 	 	 	 
	 	QTY 1-3	 	 	 	New	 	$	[***]	 	$	[***]
	 	4-10	 	 	 	New	 	$	[***]	 	$	[***]
	 	11-20	 	 	 	New	 	$	[***]	 	$	[***]
	 	21+	 	 	 	New	 	$	[***]	 	$	[***]
	RIK® Fluid Mattress (4300)	 	 	 	 	 	 	 	 	 	 
	 	QTY 1-3	 	 	 	New	 	$	[***]	 	$	[***]
	 	4-10	 	 	 	New	 	$	[***]	 	$	[***]
	 	11-20	 	 	 	New	 	$	[***]	 	$	[***]
	 	21+	 	 	 	New	 	$	[***]	 	$	[***]
	RIK® Foot Hugger	 	PP05001	 	 	 	 	 	 	 	 
	 	QTY 1-3	 	 	 	New	 	$	[***]	 	$	[***]
	 	4-10	 	 	 	New	 	$	[***]	 	$	[***]
	 	11-20	 	 	 	New	 	$	[***]	 	$	[***]
	 	21+	 	 	 	New	 	$	[***]	 	$	[***]
	RIK® Multi-Pad	 	PP01001	 	 	 	 	 	 	 	 
	 	QTY 1-3	 	 	 	New	 	$	[***]	 	$	[***]
	 	4-10	 	 	 	 	 	$	[***]	 	$	[***]
	 	11-20	 	 	 	 	 	$	[***]	 	$	[***]
	 	21+	 	 	 	 	 	$	[***]	 	$	[***]

Page 6

 
Exhibit A-Line Item Award Pricing

NOVATION L.L.C.

KCI USA Inc.

Acute and LTC Purchase Pricing  

	 
	 	PRODUCT NUMBER
	 	STATUS
	 	LIST PRICE
	 	CONTRACT PRICE

	Impression® SR"***	 	403750/403770	 	New	 	$	[***]	 	 	 
	Quantity or Eligible Tier	 	 	 	 	 	 	 	 	 	 
	1-10 or Tier 1	 	 	 	 	 	 	 	 	$	[***]
	11-20 or Tier II	 	 	 	 	 	 	 	 	$	[***]
	21-30 or Tier III	 	 	 	 	 	 	 	 	$	[***]
	31 or More, or Tier IV	 	 	 	 	 	 	 	 	$	[***]
	
Pulmonary Care	
 	

 	
 	

 	
 	
 	

 	
 	
 	

 
	Kinetic Therapysm	 	 	 	 	 	 	 	 	 	 
	Roto Rests® Delta	 	208030	 	Remfg	 	$	[***]	 	$	[***]
	TriaDyne® II	 	308550	 	New	 	$	[***]	 	$	[***]
	PediDyne®	 	204200-U	 	New	 	$	[***]	 	$	[***]
	Continuous Lateral Rotation Therapy	 	 	 	 	 	 	 	 	 	 
	Q2 Plus®	 	200700	 	New	 	$	[***]	 	$	[***]
	Bariatric Care	 	 	 	 	 	 	 	 	 	 
	BariAirtm Therapy System	 	310111	 	New	 	$	[***]	 	$	[***]
	BanKare®	 	306000	 	New	 	$	[***]	 	$	[***]
	BariMaxx	 	 	 	 	 	$	[***]	 	$	[***]
	BariMaxx Suite

(includes: BariMaxx, EZ Lift, Wheelchair,

Walker, Commode/Shower Chair	 	 	 	 	 	$	[***]	 	$	[***]
	First Step SelectTM HD	 	203800	 	New	 	$	[***]	 	$	[***]
	Bariatric Wheelchair	 	8513	 	New	 	$	[***]	 	$	[***]
	Bariatric Commode	 	47011	 	New	 	$	[***]	 	$	[***]
	Bariatric Walker	 	8512	 	New	 	$	[***]	 	$	[***]

New = Product produced by Manufacturing with all new parts and processes. 

Remfg
= Product is taken from rental fleet and remanufactured by manufacturing includes new parts only when necessary. 

Used
= Product taken from rental fleet, cleaned up, and sold as is with limited 90 day warranty. 

*
MRS Sale price is $135.00 while supplies last—5 yr. Limited Warranty 

**Price
includes air pump 

Page 7

 
EXHIBIT A-Line Item Award Pricing

NOVATION L.L.C.

KCI USA Inc.

Home Medical Equipment Pricing

Requires Contract with KCI USA and Novation HME Provider  

	Products
 
	 	PRODUCT

NUMBER
	 	Therapy

Type
	 	Retail

Daily Rental
	 	Novation HME

Daily Rental
	 	Sugggested

Sales - Retail
	 	Novation HME

Sales Price

	First Step TriCell (Two Gore-Tex Sheet)	 	212542	 	Low Air Loss	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	First Step TriCell (One Gore-Tex Sheet)	 	212500	 	Low Air Loss	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	InterCell	 	211660	 	Air Cycle	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]

Pick-up/Deliver Options: 

	1.
	Provider
pick-up and return to KCTS Service Center

	2.
	Service
Center delivery/pick-up to from Provider Center location within 50 miles

	3.
	SmartLink
Delivery Service (Overnight Program) 

All
daily placements are subject to a minimum 7 day charge at the daily rate or the actual total daily rental charge, whichever is greater. 

Mileage
beyond 50 miles from delivering Service Center will be subject to a $2.00 per mile fee. 

Most
deliveries will be made within 24 hours of receipt of a completed rental order form if Option 2 or Option 3 is chosen. 

All
rentals include cleaning fee. 

KCI
reserves the right to limit or restrict the availability in local service centers. 

SMARTLINK SERVICE  

Orders
must be received by KCTS in San Antonio by 5 p.m. (CST) for next day delivery. (Next day delivery will be completed by 10:30 a.m. in most areas. Delivery completion times may extend to 12:00
Noon and 3:00 p.m. as dictated by carrier shipping zones (some remote areas may only, have Second Day Delivery available.) 

Saturday
pick-up or delivery is a $40.00 charge. Sunday pick-up or delivery is rot available: 

	Products
 
	 	 
	 	Therapy

Type
	 	Retail

Monthly

Rental
	 	Novation HME

Monthly

Rental
	 	Sugggested

Sales - Retail
	 	Novation HME

Price

	FluidAir HC Program	 	 	 	Air Fluidized	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	maxxis 300 Series	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	39-inch	 	 	 	Bariatric	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	 	48-inch	 	 	 	Bariatric	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	 	54 inch	 	 	 	Bariatric	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	 	60 inch	 	 	 	Bariatric	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	 	78 inch	 	 	 	Bariatric	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	Maxxis 400 Series	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	39 inch	 	 	 	Bariatric	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	 	48 inch	 	 	 	Bariatric	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	 	54 inch	 	 	 	Bariatric	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]
	 	60 inch	 	 	 	Bariatric	 	$	[***]	 	$	[***]	 	$	[***]	 	$	[***]

Product is delivered by KCI. 

All
rentals include cleaning fee. 

Mileage
beyond 50 miles from delivering Service Center will be subject to a $2.00 per mile fee. 

Most
deliveries will be made within 24 hours of receipt of a completed rental order form if Option 2 or Option 3 is chosen. 

KCI
reserves the right to limit or restrict the availability in local service centers. 

Page 8

  

 
 

Attachment #2 to Exhibit A
  LETTER OF PARTICIPATION
  WITH
  KCI USA, INC.    
    

        This Novation member ("Member Facility") hereby agrees to use KCI USA Inc. as its sole source1 provider for all framed and
non-framed therapeutic support surfaces. This commitment is part of the supplier agreement between KCI USA and Novation (Contract # MS10730). The Member Facility agrees to the terms and
conditions of the Agreement regarding the sole source rental and sales of KCI USA products. All products, programs and services available under the agreement are covered under this letter of
participation. 

1
Sole Source committed volume will be measured by adding greater than or equal to [***]% utilization for wound care and pulmonary support surfaces and
[***]% utilization for bariatric support surfaces and accessories. Utilization will be measured by the member's KCI USA rental and purchase volume divided by member's total
annual rental and purchase volume for contracted categories. Volume tiers do not include The V.A.C. and V.A.C. Accessories. 

        The
duration of this sole source1 commitment agreement shall be from the first day of the month following the execution of this letter and end on at the term of the
Novation agreement. If for any reason the member facility terminates this agreement prior to the end of its term, the member facility shall pay a 15% fee as liquidated damages on the net contract
volume up to the date of termination. 

        The
pricing terms and conditions for the aforementioned products, programs and services are set forth in the Novation supplier agreement. 

        Commitment
Tier ([***]% on Wound Care and Pulmonary Products, [***]% on Bariatric Products1) (Check One): 

	Tier II	 	$[***]	 	(Sole Source)
	Tier III	 	$[***] - $[***]	 	(Sole Source)
	Tier IV	 	$[***]	 	(Sole Source)

	Novation Member Facility	 	KCI USA, Inc.
	

 Name of Member Facility	
 	

 General Manager
	

 Address, City, State	
 	

 District Number
	

 Hospital Identification Number	
 	

 Date
	

 Signature	
 	

 
	

 Title	
 	

 
	

 Date	
 	

 

KCI
USA Fax Number = 210-255-6753, Contact Julie Bennet = 210-255-6600 

Novation
Fax Number = 972-581-5210, Contact Product Manager 

1

  

 
 

Attachment 3 to Exhibit A
  Novation EXPENSE CAPs
  As of February 28, 2001    
    

	Customer Name
 
	 	City, St
 

	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	 	 	 

1

 

	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]
	[***]	 	[***]

2

  

 
 

EXHIBIT B
  
    NON-PRICE SPECIFICATIONS    
    

I. Term  

        The term of this agreement is from September 1, 2001 through [***]. 

II. Marketing Fees  

MARKETING AND SALES ADMINISTRATIVE FEES  

        Supplier agrees to pay Novation Marketing Fees on all products in accordance with Section 9a of the Novation L.L.C. Supplier Agreement as follows: 

	Contracted

Product

Category
	 	Product

Purchase1

0-75%
	 	Product

Purchase

Penetration

76-80%
	 	Product

Purchases

Penetration

81-85%
	 	Product

Purchase

Penetration

86-90%
	 	Product

Purchase

Penetration

91%
	 
	Therapeutic Support Surfaces and Overlays Rentals	 	[***]	%	[***]	%	[***]	%	[***]	%	[***]	%
	

The V.A.C. and Accessories, Other For Sale Items and Dri Flo	
 	

[***]	
%	

[***]	
%	

[***]	
%	

[***]	
%	

[***]	
%

	1
	The
parties (Supplier and Novation) will mutually agree upon baseline and target revenue penetration calculations within Member Product Purchases served by Novation.
Product Purchase Penetration will be monitored and assessed on a semi-annual basis and the percentage of marketing fees will be adjusted on a prospective basis for the following
six-month period 

SOLE SOURCE CONTRACT AWARD ADVANCED MARKETING FEE 

        Supplier
agrees to pay Novation a $[***] by December 28, 2001 an Advanced Marketing Fee for awarding a [***] sole source agreement. 

        The
purpose of the Advance Marketing Fee is to fund a marketing program, which will increase the exposure of Supplier's products within Novation and assist Supplier in increasing the
number of Members who utilize Supplier's products. The terms and conditions of the marketing program will be mutually agreed to by Supplier and Novation and will include, without limitation, the
structuring, establishment and marketing of the Wound Care Committed Program. 

EDUCATIONAL PROGRAM FUNDING  

        Supplier would provide $[***] fund standardization/utilization/best practices programs or a nursing/physicians educational programs on
advanced pulmonary care, bariatric care or advanced wound care. Supplier and Novation would agree on the structure and goals of each program prior to implementation. Payments for the educational
programs will be made over a [***]-year period—$[***] in [***] and $[***] in
[***]. 

III. VALUE BEYOND PRICE OFFERS  

A: PROGRAMS:  

Positive Outcomessm Wound Care Program:  

        The Supplier's KCI Positive OutcomesSM Wound Care Program is a continuous quality initiative utilizing a validated process1 that
provides Member wound care and clinical staff with a comprehensive 

1

 

approach
to managing the clinical and financial outcomes of pressure ulcer wound care patients in the acute care environment. Key components of this program include: 

        Protocol
standardization for prevention, early intervention and treatment of pressure ulcers. Increased effectiveness and efficiencies on managing community and hospital acquired
pressure ulcers. 

	•
	Assurance
of the proper utilization of all pressure ulcer interventions and modalities.

	•
	A
planned reduction in nosocomial pressure ulcers.

	•
	Increased
pressure ulcer documentation compliance.

	•
	Increased
quality of care and high customer satisfaction. 

        The
program utilizes a widely accepted nursing care model, which will increase the quality of care as it relates to pressure ulcer treatment in your facility. Utilizing this model, The
Positive OutcomesSM Wound Care Program is an easy four-step process. The steps of the program are outlined below: 

        The
first step begins with an assessment by conducting baseline prevalence and incidence
survey of pressure ulcers with the Member wound care team. In addition, the Supplier will assist the Member in assessing documentation compliance as it relates to pressure
ulcers. The Supplier can also assist the Member by conducting a mattress/support surface survey, which helps in the overall planning phase of the program. The Supplier recommends conducting a review
of all pressure ulcer products utilized by the Member acute care facility during this phase of the program. 

        Next,
the Supplier will help your wound care team develop a care plan for pressure ulcers by developing or modifying pressure ulcer
prevention, early intervention and treatment protocols. The Supplier has developed comprehensive pressure ulcers protocols that have been clinically validated in eighteen VHA Southeast acute care
facilities1. The protocols can be adapted to specially meet a Member's clinical needs and are available in written or algorithm formats. A key goal during the planning phase of the
Positive OutcomesSM Wound Care Program is reducing nosocomial pressure ulcers by a specified amount or percentage based on the baseline survey data and protocols 

1Managing Pressure Ulcers: A Multisite CQI Challenge" Nursing Management Volume 30 Number 10 October 1999 

        Implementation of the pressure ulcer treatment plan includes extensive wound care education and in-service training on all
products from the Supplier and other suppliers. The Supplier is an accredited provider of continuing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). The
Supplier will also assist you in auditing the progress of the Supplier's Positive OutcomesSM Wound Care Program by providing resources to conduct nursing care unit prevalence and
incidence Surveys, documentation and protocol audits and can even provide the Member acute care facility with its Odyssey Comprehensive Wound Management Software. 

        The
final step includes a reassessment by conducting a follow-up prevalence and incidence survey of pressure ulcers and a
review of the pressure ulcer treatment plan in light of findings. 

        The
KCI Positive OutcomesSM Wound Care Program will meet Member acute care facility objectives of providing high quality outcomes at the lowest total cost. By combining
therapeutic surface purchases and rentals, each Member acute care facility maximizes the technologies being used with documented cost savings and increased rate of return. 

Odyssey Comprehensive Wound Management Software:  

        Odyssey is a comprehensive wound management PC based software program designed to assist the care giver in assessing patient risk of skin breakdown; tracking
wound healing progression; tracking therapeutic prevention and treatment interventions including Therapeutic Support Surfaces and 

2

 

Specialty
Beds, topical treatments and other modalities; and reporting patient specific clinical outcome or financial information for clinical and management review. 

        Odyssey
will monitor protocol compliance for the prevention and treatment of wounds and help standardize the documentation process and reduce the need for documentation duplication. 

        Odyssey
will allow the facility to predict the outcome of various treatments and create a timeline or clinical critical path based on the data entered about wounds treated in the
facility. Odyssey track costs associated with wound care for the facility i.e. surfaces, topicals, nutrition, lab tests, labor. 

        Odyssey
will be made available to each Member health care organization for [***] each installation. Committed participants may pay a licensing fee of
[***] per year. Member Health care organizations participating in the Wound Care Committed Program will have for their use one installation of Odyssey at no charge. 

Novation/KCI USA National Prevalence and Incidence Survey  

        Supplier will team with Novation to develop a national recognized quality initiative for the prevention and treatment of community and hospital acquired pressure
ulcers in acute care facilities. The goals of the program are: 

	•
	Provide
a benchmark for Novation and Member health care organizations to measure quality outcomes.

	•
	Provide
a methodology for a continuous quality improvement process and protocol validation.

	•
	Facilitate
a platform for a standardized, facility-wide ulcer education program.

	•
	Help
Member health care organizations assess the financial impact of pressure ulcer prevention and treatment.

	•
	Help
Member health care organizations fine tune skin health protocols.

	•
	Identify
risk management issues by care setting. 

        Supplier
will provide prevalence and incidence study kits, which include, an educational video, an interrater reliability testing method and prevalence and incidence study forms. 

        Member
health care organizations will need to provide a facility champion/study director and teams of clinicians to assess and gather data. In most cases when requested, Supplier account
executives and clinical consultants assist in the survey. 

        Supplier
will provide the data entry and analysis to create the national database results. The results will be published in a national peer reviewed journal (Journal of Wound, Ostomy,
and Continence Nursing—July 2000*Volume 27*Number4). 

        This
service, if purchased by a Member health care organization would be approximately $[***]. 

Activity Based Pricing-Consigned Inventory  

        Supplier will extend up to a [***] ([***]%) unit pricing discount to Member health care organizations that store
Supplier contracted products on site and place non-emergency patients on these products after 5:00 P.M. and before 8:00 A.M. The discount applies to stored products only. 

        In
addition, Supplier will consign inventory when appropriate to meet the delivery needs of Members health care organizations when the inventory can be utilized at mutually acceptable
levels. 

3

 

Simple & Simple Plus Program.  

        The Supplier's Skin Integrity Management Program for Long Term Excellence (hereinafter referred to as "SIMPLE") is a new and innovative program designed to
address skin care challenges within Member extended care facilities. SIMPLE will enable the Member to provide a skin care program for its residents at a fixed cost in order to meet the challenges
presented by the Medicare Prospective Payment System and other fixed reimbursement payers. Information and statistics regarding the facility, its residents and its patient care policies is crucial to
the success of SIMPLE. Product selection is dictated by a prevalence benchmarking study, which will then be linked to the SIMPLE & SIMPLE Plus Decision Tree. Once support surface selection
protocols have been established by the facility facility, those protocols will be added to the facility's comprehensive wound care prevention and treatment protocols. 

        The
SIMPLE Program is a pressure ulcer prevention and early intervention program, which includes comprehensive clinical support on a regularly scheduled basis and the provision of
specialty support surfaces on all licensed beds at a fixed cost. The SIMPLE Plus Program includes all of the benefits of the SIMPLE Programs plus a pressure ulcer treatment program, which makes
available to the facility the advanced support surfaces, required to treat patients admitted to the facility with pressure ulcers on a fixed cost basis. Baseline clinical parameters include the
patient's mobility status and prevalence of wounds in relation to available patient turning surfaces. These factors are instrumental in the selection of appropriate support surfaces. The program
provides assurances that if a patient develops a pressure ulcer, Supplier will provide an aggressive therapy bed at no charge. 

        The
therapy available for a particular patient will be determined based on the SIMPLE decision tree. Therapies available within the program include the following Products: 

First
Step® Family

DynaPulse®

KinAir ® III

TheraPulse

RIK ® Fluid Mattress

FluidAir ® Family 

B. TRAINING & INSERVICE  

Clinical Rounds:  

        The Supplier will provide professional and valuable rounds of patients being treated by the Supplier Product therapies used by Member health care organizations at
no charge. The Supplier national staff of clinical consultants ensures timely, efficient clinical training, education, advice and service to patients and acute, long term care and home health agency
personnel by assisting with patient placement, consultations, instructing clinical staff in safe and effective use of Supplier equipment and therapies, and provides supplementary visits to assure
maximum patient benefit. The clinical consultants assist in matching products to clinical diagnosis and assist in determining product appropriateness including recommendations to step down or
discontinue therapies based on the reviewing assessment of patient needs. In addition, during clinical rounds the Supplier clinicians manage the Product therapy, provide new Product Gore Tex sheets or
supervise V.A.C Product dressing changes and adjust settings as appropriate. 

Specialized Clinical Rounds for Pulmonary Patients:  

        The Supplier clinical consultants are providing Member health care organization specifically designed ICU/CCU rounding to assure the clinical success of Supplier
Kinetic Therapy Products. The 

4

 

special
rounds include tracSking the pulmonary function status of the intubated pulmonary compromised patient and working with the ICU clinical staff to determine patient progress. 

Product Inservices:  

        Supplier will provide product inservices at anytime for any Member contracted product utilized on this contract at no charge. 

Clinical Protocol Guarantee:  

        If a Member acute or long-term care facility has specific protocols established and the Supplier has been notified of the protocols in writing, the
Supplier will strictly adhere to them for proper patient placement. In the event that a Member acute or long term care facility believes a less expensive Supplier Product would have been more
appropriate for a specific patient based on its protocol, the Supplier will credit the facility for all Product Support Surfaces charges associated with that patient until the time of modification.
The Member acute or long-term care facility must notify the Supplier within 72 hours after placement. The Supplier and the Member acute or long-term care facility will
then meet to review existing protocols to ensure future placements are suitable. 

Indigent Care Product Placement  

        Committed Member Acute Care Hospitals may utilize up to one wound care overlay (RIK and First Step Plus) at no charge per day to care for it's indigent patients.
The patients must be designated as indigent at time of order. Documentation of indigence must be provided upon request. This program is available to any Member acute care facility with a minimum of
$[***] in annual surface rental utilization. 

Specialized Patient Care Team And Medical Hotline  

        The Supplier specialized patient care teams provide one-on-one consulting with staff physicians, nurses and other clinicians with Member
health care organizations. Additionally, the Supplier Patient Care Team is on call around the clock, including a 24-hour availability of our staff physicians and nurses
(800) 531-5346. 

C. EDUCATION PROGRAMS  

        Supplier Executives and Clinical Consultants are specially trained to provide educational programs at member organizations. Supplier is an accredited provider of
continuing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). The following courses are available at Member health care organizations at no charge in support
of the contract. 

AHCPR Prevention Guidelines            2.0 Contact Hours  

        Objectives: 

	•
	Identify
adults at risk for Pressure Ulcers

	•
	Define
early interventions for prevention and treatment of pressure ulcers.

	•
	Discuss
the use of the AHCPR Guidelines to develop protocols for pressure ulcer interventions. 

Assessment and Documentation of Pressure Ulcers            1.0 Contact Hours  

        Objectives: 

	•
	Identify
adults at risk individuals and the specific factors placing them at risk. 

5

 

	•
	Describe
the four stages of development of a pressure ulcer.

	•
	Identify
appropriate criteria for the development of skin breakdown. 

AHCPR Treatment Guidelines: Ulcer Care            3.0 Contact Hours  

        Objectives: 

	•
	List
four methods of debridement.

	•
	Discuss
the wound cleansing and infection control procedures recommended by the AHCPR Treatment guidelines.

	•
	List
and discuss the four criteria for choosing an appropriate ulcer care dressing. Discuss adjunctive therapies and operative repair for pressure ulcers 

Implementation Strategies for Pressure Ulcer Prevention            1.0 Contact Hours  

        Objectives: 

	•
	Identify
adults at risk for pressure ulcers.

	•
	Define
interventions for skin care, early treatment and mechanical loading. Discuss the use of education programs to reduce the incidence of pressure ulcers. 

AHCPR Treatment Guidelines: Ulcer Care            1.5 Contact Hours  

        Objectives: 

	•
	List
four debridement methods.

	•
	Discuss
the wound cleaning and infection control procedures recommended by the AHCPR treatment guidelines.

	•
	List
and discuss the four criteria for choosing a pressure ulcer dressing.

	•
	Discuss
adjunctive therapies and operative repair for pressure ulcers. 

Position in Life is Everything—Kinetic Therapy            1.0 Contact Hours  

        Objectives: 

	•
	Discuss
the importance of motion to the human body.

	•
	Identify
the complications of immobility.

	•
	Discuss
how positioning can resolve the complications of immobility.

	•
	Review
Kinetic Therapy research results that demonstrate clinical and financial outcomes.

	•
	Define
nursing guidelines to appropriately use Kinetic Therapy. 

Customized Novation On-Site Seminars  

        Supplier will provide speakers for large Wound Care Management seminars. These seminars are organized by Supplier and have an expected attendance of a least one
hundred or more healthcare professionals who are responsible for chronic wound management. 

6

 

Bariatric Education Program:  

        A comprehensive bariatric education program will be available. This program will contain 12 sections, which may be presented in either an In-service
format or self-study, to be determined by the specific needs of the facility. A quarterly newsletter with research and utilization updates including specialized sections addressing
maintenance and improvements of Activities of Daily Living (ADL), bariatric specific pathophysiology and interventions and psychosocial interactions and will also be provided. This basic education
program currently encompasses the following specific bariatric information: 

        Comprehensive
Assessment Criteria and Therapeutic Clinical Interventions: 

Airway

Cardiovascular

Neurological

Gastrointestinal

Genito-urinary

Integument

Psychosocial

Functional (ADL's)

Laboratory Analysis

Pain Assessment

Medication

Nutrition 

        A
comprehensive bibliography will also be included for additional references as needed by the healthcare provider. 

Centers of Excellence Educational Programs (Available to VHA and UHC Member Health Care Organizations)  

Wound
Care Grand Rounds Program

Wake Forest University School of Medicine

Wake Medical Center—Raleigh, North Carolina

Moderators: Louis C. Argenta MD, Michael J. Morykwas PhD. 

        The
wound care grand rounds program is a one day program conducted at Wake Forest University School of Medicine in Raleigh, North Carolina and is primarily focused on the clinical
challenges of treating of acute and chronic wounds. 

        The
objective of the program is to provide an in-depth understanding and the scientific research behind new intervention and treatments for multiple wound care indications.
Physician disciplines from burn, trauma, orthopedic trauma, vascular and plastic surgery present case studies focused on acute and chronic wounds. 

Pulmonary Preceptor Program  

Grady
Health System—Atlanta Georgia

Moderator: Barbara McLean, MN, RN, CCRN, CRNP 

        The
Pulmonary Preceptor Program is a new 2-day mentor-extern program at Grady Memorial Hospital in Atlanta, Georgia. 

        The
program is focused on the clinical challenges of the immobile patient. The objectives of the program provide a structured lecture on ventilation, gas exchange, perfusion, and
hemodynamics. 

7

 

Grand
rounds are conducted with Grady Health System nurses and physician staff. Course instruction will include X-ray rounds of evaluating patients, bedside analysis with
x-ray, ABGVBG, laboratory values and patient data sheet, bedside discussions with primary nurse and physician regarding therapy interventions and ventilator analysis and oxygenation
review. 

D. SERVICE  

Service Response Time and Novation/Supplier Kustomer Care Initiative:  

	•
	Supplier
is dedicated to continuous quality improvement in all aspects of our business. In an effort to provide Novation Member health care organizations with excellence in
customer service, Supplier will offer the Novation Kustomer Care Program.

	•
	KCI
USA/Novation Kustomer Care Service Hotline:

	•
	The
Supplier always has the Member health care organization patients' outcomes and best interests at heart. The KCI USA/Novation Kustomer Care Program is a major investment
by Supplier to provide Members with outstanding business information, clinical, and service satisfaction. In the event that Supplier does not meet Member needs, the KCI USA/Novation Customer Care
Program will allow Member health care organizations to call a Supplier customer service representative via a toll free Supplier Customer Care Service Hotline at
1-888-ASK-4-KCI extension 7. Within two hours of the Member call, the Supplier General Manager responsible for the business information, clinical, and
service requirements for the specific Member health care organization will contact the Member to discuss the issue and develop a plan for prompt resolution of the issue at hand. In addition, within
forty-eight hours of the call, a Supplier operations manager will follow-up to verify that the Member health care organization's requirements have been satisfied. 

KCI USA Kustomer Care Comment Cards:  

	•
	Supplier
will also solicit input on the service provided. The Suppliers implements a continuous quality program that includes feedback from Members. Over the first
twenty-four months, Member health care organizations will be provided prepaid customer comment cards, which will be randomly attached to Supplier therapy Product placements and pickups.

	•
	KCI
USA/Novation Kustomer Care Webpage Address:

	•
	The
Supplier will maintain access of the KCI USA/Novation Kustomer Care webpage at www.KCIl.com/Novation.html to find the KCI USA/Novation Customer Care Program comments
page.

	•
	At
Supplier, if Member health care organizations are not completely satisfied with the service that is being provided to them, they want to hear from Novation and the
specific Member health care organization. As set forth below, the Supplier Customer Care Program provides the
Member with an explanation of the essential performance objectives that the Supplier organization strives to achieve with each business, clinical and service call to the Member institution to help
ensure the highest level of customer satisfaction. 

Service Performance Objectives:  

	•
	Delivery
of the Supplier's "critical care" products, (marketed under the trade names of RotoRest® Delta, TriaDyne®, BariKair®, and
BariAir® Therapy System) will be delivered to you within [***] plus driving time from the time the order is placed and processed. 

8

 

	•
	Delivery
of non-critical products, those Supplier Products, which are not "critical", will be delivered within [***] hours
([***] as appropriate) from the time the order is placed and processed.

	•
	Supplier
will deliver the product ordered and bill for the product, which is delivered. If the product ordered is not available, Supplier will offer Novation health care
organizations' clinicians an available substitution and will bill at the lesser of the two product prices. The Supplier Service Consultant can also provide ancillary support in delivering, installing
and adjusting traction bars, lifts, and transport airs. In addition, if requested by the Member, the Supplier Service Consultant can reset or calibrate the bed scales and performing equipment
maintenance checks. 

Clinical Support Performance Objectives:  

	•
	The
Supplier Clinical Consultants provide clinical support to help Member health care organizations reach their organizational, clinical and financial goals.

	•
	These
dedicated Supplier team members ensure timely and efficient service to the Members patients and hospital personnel by assisting with patient placement consultations,
providing supplementary visits to assure maximum patient benefit and making rounds to track individual patients progress, reassess patients if necessary and to make sure the product is performing
properly.

	•
	The
Supplier Clinical consultants are certified to present both formal and informal educational programs, and provide clinical in-service training on the safe
and effective use of Supplier Products and therapies.

	•
	The
Clinical Consultants are trained to assist in protocol development and documentation/reimbursement assistance. 

Business Performance Objectives:  

        Supplier will provide Member health care organizations with clear and accurate invoices. Each 

	•
	Supplier
account executive will provide Member health care organizations with a written acknowledgment form or contract stating the pricing and billing terms of each of our
products. Products will not be billed until the Member health care organization has the approved price entered into the Supplier's system.

	•
	Supplier
defines the terms of the Product Rental as beginning on the day that the Product is delivered to the Member facility. To discontinue service, each Member health
care organization can call the toll free Advantage Center number at 1-888-ASK-4-KCI. At the time of the call, a stop billing confirmation number will be
issued confirming that rental is discontinued on that day.

	•
	Supplier
has developed a specific business review format that details all information on product mix, product billings, therapy days, and length of stay. Either the Members,
Supplier General Manager or Account Executive can formally present the Supplier business review to the Member facility as often as necessary. 

Health Care Organization Business Reviews:  

	•
	Supplier
General Managers have been trained to provide Novation Health Care Organizations with business review information and consultation that details contract information
on product 

9

 

mix,
product billings, therapy days and length of stay. The Supplier General Manager can meet with key decision-makers within Members Health Care Organizations as often as necessary. 

Service Agreements and Warranties  

        Attachment 1 to Exhibit B 

        Billing Practices:    Supplier defines the terms of the Product Rental as beginning on the day that the Product is delivered to
the Member facility. To discontinue the service the Member can call 888-ASK-4KCI. The Member will cease being billed at that time and a stop billing confirmation number will be
issued and Member's charges for the service discontinued. 

E. CONVERSION AND IMPLEMENTATION PLAN:  

Supplier Sales Training Program:  

        Supplier will work with the Novation Director, Wound Care Products to develop and launch are appropriate marketing package. 

        Within
30 days after notification of the award, Supplier will conduct regional meetings with all Supplier staff to educate each Supplier team Member about the new contract
components and benefits and communicate the launch plan. 

Novation Service Delivery Account Executive Training Program  

        Supplier will work with Novation Director, Wound Care Products and Vice Presidents of Sales for Service Delivery to develop and launch marketing package and to
train the Novation service delivery teams of VHA and UHC. 

        Supplier
will work with the Novation Director, Wound Care Products and Vice Presidents of' Sales for Service Delivery to develop and launch an appropriate marketing package and to train
the Novation teleservices department. 

        Representatives
of Supplier will attend VHA Regional Materials Management Meetings 

        Supplier
will work with Vice Presidents of Sales for Novation Service Delivery to develop and attend and present the contract at all VHA materials management meetings. 

        Representatives
of Supplier shall work with Novation communications to create a Press Release announcing the newly awarded Agreement. 

F: BARIATRIC PRODUCT SERVICE ADDITIONS  

	•
	Bariatric
Products Service: The Supplier will offer Members a dedicated toll free number 1-888-ASK-4KCI (extension 7) for service
calls. The Supplier's General Manager responsible for the Bariatric Products will call to discuss the Member issue and develop a plan for prompt resolution of the issue.

	•
	Service
Consultant Training—Supplier will train and re-certify the service consultants on the service and repair of all Supplier Bariatric Products
by August 1, 2001.

	•
	Bariatric
Product Availability—If a Member places an order for the rental of a Supplier's Bariatric bed or surface and it is not delivered within
24 hours, the Supplier will credit the Member with a no charge day for that day and every full day thereafter until a bed is delivered, or upon agreement with the Member, Suppler will offer an
acceptable substitute Product and chare the Member for the less expensive of the two Products. 

10

  

 
 

Attachment 1 to Exhibit B
  Sheet & Cushion Service Agreement    
    

        KCI USA offers to its customers a sheet and cushion service on any appropriate product sold. The Sheet & Cushion Service Agreement has several features: 

	•
	The
Agreement is available for purchase by healthcare facilities only

	•
	The
Agreement may be purchased at any time

	•
	The
Agreement is based on two deliveries per month

	•
	The
Agreement is available in either a Standard or Premium service 

Standard
Service 

	•
	KCI
will deliver and pick-up sheets and cushion/mattresses on a designated schedule. (The account will be responsible for the disassembly and reassembly of the
bed.)

	•
	All
activity will be scheduled during normal business hours (8 am to 5 pm: Monday - Friday) 

Premium
Service 

	•
	KCI
will deliver and change the appropriate sheets and cushion/mattresses on a designated delivery/service schedule. The account will be responsible for any changes in the
designated delivery/service schedule)

	•
	The
frame and/or box will be cleaned in accordance with KCI Infection Control Procedures

	•
	All
electric and mechanical functions will be checked per KCI's quality check list. Any deficiencies will be noted and the information provided to the appropriate department
within the facility.

	•
	All
activities will be scheduled during normal business hours (8 am to 5 pm: Monday - Friday) 

Program
Cost 

	Type of

Service
	 	Facility within 25 miles of a KCI Service Center
	 	Facility within 25 - 50 miles of KCI Service Center
	 	Facility within 50 - 75 miles of a KCI Service Center
	 	Facility beyond 75 miles of a KCI Service Center

	STANDARD	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]
	PREMIUM	 	$	[***]	 	$	[***]	 	$	[***]	 	[***]

1

 
 
 

Extended Warranty Agreement    
    

        KCI USA offers an extended warranty on any new product sold. The extended warranty is available for a period of one year from the expiration date of the original
warranty. The extended warranty must be purchased at the time of the initial sale. 

        The
extended warranty conditions can be summarized as: 

	•
	The
warranty period begins one year from the invoice date of original equipment purchase.

	•
	The
warranty is not transferable.

	•
	KCI
will replace or repair (at KCI's option) any defective parts or entire system covered under this Agreement.

	•
	No
returns or replacements will be accepted without prior written authorization from KCI.

	•
	This
warranty does not include any shipping and handling costs and/or disposal fees.

	•
	This
warranty does not cover:

	•
	Normal
wear and tear

	•
	Patient
wearable surfaces

	•
	Mattress,
cushion, or fabric components

	•
	Damage
due to causes beyond KCI's control 

        The
extended warranty agreement includes the use of a compatible loaner surface if the repair to the facilities surface requires its removal from the facility. Product covered by the
extended warranty will be guaranteed to be "patient ready" 95% of the time. 

2

 
 
 

Product Maintenance Agreement    
    

        KCI USA offers its customers optional product maintenance agreements. These agreements are designed to provided you with confidence that your KCI product will
function properly for years to come. Three options are available. 

No Coverage  

        Any product repairs not covered by the original product warranty, extended product warranty or other repair agreement will be charged the following fees: 

	• Parts	 	 	[***]
	• Labor	 	$	[***]/ hour
	• Travel	 	 	[***]¢ per mile
	• Parking	 	 	[***]
	• Tolls	 	 	[***]
	• Emergency	 	 	[***]

Basic Coverage  

        The Basic Coverage plan protects you from the unknown variable repair expense that could occur. Basic Coverage offers the following: 

	• Parts	 	[***]% discount
	• Labor	 	[***]
	• Travel	 	[***]¢ per mile
	• Parking	 	[***]
	• Tolls	 	[***]
	• Emergency	 	[***]

Total Coverage  

        The Total Coverage plan offers complete protection from any problems that might occur. This plan offers: 

	• Parts	 	[***]
	• Labor	 	[***]
	• Travel	 	[***]
	• Parking	 	[***]
	• Tolls	 	[***]
	• Emergency	 	[***]

        Pricing
for each product plan varies from product to product. All product services are provided during normal business hours (8 AM to 5 PM / Monday - Friday). Emergency service is not
available in all locations. 

3

  

 
 

EXHIBIT C
  SPECIAL CONDITIONS    
    

I. WOUND MANAGEMENT COMMITTED PROGRAM\  

        Supplier agrees to participate in a Novation Wound Management Committed Program and will commit the following incentives and resources for the program: 

Wound Management Committed Program Incentive Value:  

        Suppler will pay [***] ([***]%) incentive to Members that meet the participation criteria in accordance to the
terms and conditions of a future Wound Management Committed Program according to the following schedule: 

	Product Categories
 
	 	Incentives
	 
	Wound Care (excluding V.A.C. Products), Pulmonary and Bariatric Products	 	[***]	%

1New
products may be added at the mutual agreement of Novation and Supplier. 

        Member
Health care organizations participating in the Wound Management Committed Program will have for their use one installation of Odyssey at no charge. 

        Member
health care organizations participating in the Novation Wound Management Committed Program will have for their use a customized version of Odyssey, which will include a
preprogrammed list of contracted products and protocols. By customizing Odyssey to include the Wound Management Committed Programs, Member health care organizations, which will help increase
compliance and outcomes, drive standardization and utilization and track financially all of the economic components of the program. 

II. OPPORTUNITYSM PHASE II MEMBERS:  

        Supplier will allow Members marked compliant in Novation's OPPORTUNITYSM Phase II Members (identified in Attachment 1 to Exhibit C) the opportunity
to access the Product Pricing in this Agreement effective July 1, 2001. The Member will be eligible based on signing the Letter of Commitment form in Exhibit A. with Product pricing becoming
effective after receipt by Supplier. Novation and Supplier will mutually agree upon the communication/m arketing of the early access to the Agreement. 

1

  

C=Compliant 

 
 

Attachment 1 to Exhibit C
  OPPORTUNITY-COMPLIANT KCI LIST    
    

	SYSTEM ID—MEMBERSHIP
 
	 	PARENT ID
	 	# Facilities
	 	MEMBER NAME
	 	CITY
	 	STATE
	 	MEMBER

CLASS NAME
	 	KCI Old

Contract

(MS80180)

	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Office Affiliate	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Network Affiliate	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Page 1

 

	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Affi	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Affi	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Control	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Page 2

 

	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Affi	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Office Affiliate	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Parnter	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Page 3

 

	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Parnter	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Member Control	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Page 4

 

	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Aff	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Affi	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Page 5

 

	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Control	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Office Affiliate	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Page 6

 

	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Control	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controllt	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner Controll	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Cor	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Aff	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Partner	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Office Affiliate	 	C
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	Waiver
	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	[***]	 	Shareholder Co	 	Waiver

Page 7

  

	 	 	 	 	NovationTM
	 	 	 	 	The Supply Company of VHA & UHC
	 	 	EXHIBIT D	 	 
	 	 	Award Letter	 	125 East John Carpenter Freeway

Suite 1500

Irving, TX 75062-2324
	

 	
 	

 	
 	

P.O. Box 140909

Irving, TX 75014-0909
	

 	
 	

 	
 	

972/581-5000

April 15, 2001 

Scott
Brooks

Vice President, National Accounts

KCI USA

8023 Vantage Drive

San Antonio, TX 78230 

	1.
	Subject: Acceptance of Bid (Supplier Agreement # MS10730)

Dear
Scott, 

        Novation,
LLC ("Novation"), acting in its capacity as agent for VHA, UHC, and HPPI, respectively (and not collectively) and certain of their respective subsidiaries and affiliates,
accepts your [sole-source, dual supplier] proposal for [product category] in response to our Invitation To Bid for Therapeutic Specialty
Beds, Therapeutic Surfaces & Related Products dated October 6, 2000, which was signed and dated by you on November 5, 2000. Also, attached to this Award Letter is Exhibit H
(Exceptions to Supplier Agreement # MS 10730). 

        The
"Agreed Percentage" for the Marketing Fee will be as outlined in the chart below: 

	Percent Market Share
 
	 	0%-75%
	 	76%-80%
	 	81%-85%
	 	86%-90%
	 	Greater than

90%
	 
	PRODUCT CATEGORY	 	Marketing Fee Percentage	 	 	 	 	 
	Therapeutic Support Surfaces and Bed Rentals	 	[***]	%	[***]	%	[***]	%	[***]	%	[***]	%
	V.A.C Rentals and Accessories, Dri-Flo and For Sale Items	 	[***]	%	[***]	%	[***]	%	[***]	%	[***]	%

        Also,
attached are the final agreed upon Exhibits to the Supplier Agreement as listed below: 

Exhibit A:
Products and Service Description

Exhibit B: Non-Price Specifications

Exhibit C: Terms of Supplier's Participation in Committed Programs

Exhibit D: Award Letter

Exhibit E: Electronic Data Interchange

Exhibit H: Exceptions to Supplier Agreement

Exhibit F: Neoforma Master Supplier Agreement

Exhibit H: Exceptions to the Supplier Agreement 

        The
term of this Agreement will be for a period of [***] years, effective September 1, 2001. 

        Novation
looks forward to a successful implementation of this Agreement. 

Sincerely,

Mark
M. McKenna

President

Novation, LLC 

1

  

	 	 	 	 	NovationTM
	 	 	 	 	The Supply Company of VHA & UHC
	 	 	EXHIBIT D	 	 
	 	 	Award Letter	 	125 East John Carpenter Freeway

Suite 1500

Irving, TX 75062-2324
	

 	
 	

 	
 	

P.O. Box 140909

Irving, TX 75014-0909
	

 	
 	

 	
 	

972/581-5000

April 15, 2001 

Scott
Brooks

Vice President, National Accounts

KCI USA

8023 Vantage Drive

San Antonio, TX 78230 

	1.
	Subject: Acceptance of Bid (Supplier Agreement # MS10730)

Dear
Scott, 

        Novation,
LLC ("Novation"), acting in its capacity as agent for VHA, UHC, and HPPI, respectively (and not collectively) and certain of their respective subsidiaries and affiliates,
accepts your
[sole-source, dual supplier] proposal for [product category] in response to our Invitation To Bid for Therapeutic Specialty Beds,
Therapeutic Surfaces & Related Products dated October 6, 2000, which was signed and dated by you on November 5, 2000. Also, attached to this Award Letter is Exhibit H
(Exceptions to Supplier Agreement # MS 10730). 

        The
"Agreed Percentage" for the Marketing Fee will be as outlined in the chart below: 

	Percent Market Share
 
	 	0%-75%
	 	76%-80%
	 	81%-85%
	 	86%-90%
	 	Greater than

90%
	 
	PRODUCT CATEGORY	 	Marketing Fee Percentage	 	 	 	 	 
	Therapeutic Support Surfaces and Bed Rentals	 	[***]	%	[***]	%	[***]	%	[***]	%	[***]	%
	V.A.C Rentals and Accessories, Dri-Flo and For Sale Items	 	[***]	%	[***]	%	[***]	%	[***]	%	[***]	%

        Also,
attached are the final agreed upon Exhibits to the Supplier Agreement as listed below: 

Exhibit A:
Products and Service Description

Exhibit B: Non-Price Specifications

Exhibit C: Terms of Supplier's Participation in Committed Programs

Exhibit D: Award Letter

Exhibit E: Electronic Data Interchange

Exhibit H: Exceptions to Supplier Agreement

Exhibit F: Neoforma Master Supplier Agreement

Exhibit H: Exceptions to the Supplier Agreement 

        The
term of this Agreement will be for a period of [***] years, effective September 1, 2001. 

        Novation
looks forward to a successful implementation of this Agreement. 

Sincerely,

Mark
M. McKenna

President

Novation, LLC 

1

  

 
 

EXHIBIT E
  
    OTHER INFORMATION REQUIREMENTS    
    

        Novation and Supplier desire to facilitate contract administration transactions ("Transactions") by electronically transmitting and receiving data in agreed
formats in substitution for conventional paper-based documents and to assure that such Transactions are not legally invalid or unenforceable as a result of the use of available electronic technologies
for the mutual benefit of the parties. 

        The
parties agree as follows: 

1. PREREQUISITES.  

        a.     Documents; Standards. Each party will electronically communicate to or receive from the other
party all of the required documents listed in the Novation Electronic Communication Requirements Schedule attached hereto (collectively "Documents"). All Documents will be communicated in accordance
with the standards set forth in the applicable sections of the Novation Information Requirements Guidebook ("Guidebook"). Supplier agrees that the Guidebook is the Confidential Information of Novation
and will not disclose information contained therein to any other party. 

        b.     Third Party Service Providers. Documents will be communicated electronically to each party, as
specified in the Guidebook, through any third party service provider ("Provider") with which either party may contract or VHAseCure.netTM. Either party may modify its election to use, not
use or change a Provider upon thirty (30) days' prior written notice. Each party will be responsible for the costs of any Provider with which it contracts, unless the parties otherwise mutually
agree in writing. 

        c.     Signatures. Each party will adopt as its signature an electronic identification consisting of
symbol(s) or code(s) which are to be affixed to or contained in each Document transmitted by such party ("Signatures"). Each party agrees that any Signature of such party affixed to or contained in
any transmitted Document will be sufficient to verify such party originated and intends to be bound by such Document. Neither party will disclose to any unauthorized person the Signatures of the other
party 

2. TRANSMISSIONS.  

        a.     Verification. Upon proper receipt of any Document, the receiving party will promptly and properly
transmit a functional acknowledgment in return, unless otherwise specified in the Guidebook. 

        b.     Acceptance. If acceptance of a Document is required by the Guidebook, any such Document which has
been properly received will not give rise to any obligation unless and until the party initially transmitting such Document has properly received in return an Acceptance Document (as specified in the
Guidebook). 

        c.     Garbled Transmission. If any properly transmitted Document is received, in an unintelligible or
garbled form, the receiving party will promptly notify the originating party (if identifiable from the received Document) in a reasonable manner. In the absence of such a notice, the originating
party's records of the contents of such Document will control. 

3. TRANSACTION TERMS.  

        a.     Confidentiality. No information contained in any Document or otherwise exchanged between the
parties will be considered confidential, except to the extent provided by written agreement between the parties, or by applicable law. 

        b.     Validity; Enforceability. Any Document properly transmitted pursuant to this Agreement will be
considered, in connection with any Transaction, to be a "writing" or "in writing"; and any such Document when containing, or to which there is affixed, a Signature ("Signed Documents") will be 

1

 

deemed
for all purposes to have been "signed" and to constitute an "original" when printed from electronic files or records established and maintained in the normal course of business. 

4. STANDARDS.  

        ASC × 12—Novation Information Requirements Guidebook 

5. Third Party Service Providers.  

        (If the parties will be transmitting Documents directly, insert "NONE") 

	Company
 
	 	VAN Name
	 	Address
	 	Telephone

Number

	Novation	 	AT&T

Bridgeton, MO 63044	 	12976 Hollander Drive	 	800/624-5672

6.    CONTRACT PRICING (PHARMACY).    Supplier will transmit contract-pricing information electronically, to include new contracts,
contract renewals, and any changes to a current contract. This will be sent in a timely manner and in compliance with ANSI ASC X12-845 (Price
Authorization) and Novation Contract Pricing Guidelines. Contract pricing information will include the following: 

Supplier
Identification Number

        HIN (Health Industry Number if Supplier is a HIN subscriber)

        DEA Number (if HIN is not available)

        Supplier Assigned Number (if HIN and DEA are not available) 

Supplier
Name

Supplier Contract Number

MFG Contract Number

Contract Effective Date

Contract Expiration Date

Member(s) (Member name, HIN or DEA number, Member start/stop dates)

Product Identifier

        NDC

        UPC (if NDC is not available)

Trade Name

Package Count

Package UOM

Selling Unit Price

Item Contract Effective Date

Item Contract Expiration Date 

7.    CONTRACT PRICING (MEDICAL/SURGICAL).    Supplier will communicate contract-pricing information electronically, to include new
contracts, contract renewals, and any changes to the current contract. This will be sent in a timely manner and in compliance with the Guidebook. 

2

  

 
 

Novation Electronic Communication
  Requirements Schedule    
    

	Company Name:	 	 	 	Date:
	KCI USA	 	 	 	11/06/00
	

Your Name:	
 	

 	
 	

Your title
	Sam Peace	 	 	 	Vice President Information Services
	

Phone:	
 	

Fax:	
 	

E-mail
	210-255-6940	 	210-255-6904	 	peaces@kcil.com
	

Technical Contact:	
 	

 	
 	

Title
	Sam Peace	 	 	 	Vice President
	

Phone:	
 	

Fax:	
 	

E-mail:
	210-255-6940	 	210-255-6904	 	peaces@kcil.com
	 	 	 	 	 

	NOVATION REQUIREMENT
 
	 	NOVATION EXPECTATION
	 	MANDATORY DUE DATES & FORMATS TO BE USED

	Requirement 1: New Contract Launch

Section 4.1, page 21 of the 2000 Guidebook	 	This only applies to new contracts, unless your company never provided this information. If needed, your Novation product manager will contact you. UPN must be included with all line item files.	 	Due 60 days prior to the Contract Effective Date
	Requirement 2: Ongoing Contract Maintenance.

Section 4.2, page 27 of the 2000 Guidebook	 	Novation must receive contract item and pricing updates as prices change, and when items are added or deleted from contract.	 	Due 60 days prior to the effective date of the line item add/delete/change
 Information will be sent via (check one):

(X) EDI 832

(   ) Interim File Format (Excel Spreadsheet)
	Requirement 3 Summary Sales Reporting

Section 4.3, page 43 of the 2000 Guidebook	 	Current paper reports must be converted to electronic reporting immediately.	 	Due at the first contract reporting period
	Requirement 4: Detailed Line Item Sales Reporting

Section 4.4, page 51 of the 2000 Guidebook	 	Plan for a 90-day testing for this requirement.	 	Begin testing within 120 days of Contract Effective Date Information will be sent via (check one):

(X) EDI 867

(   ) Other
	Requirement 5: Membership Section 4.5, page 63 of the 2000 Guidebook	 	You must be able to receive and process monthly membership updates.	 	Due immediately
	Requirement 6: Commitment Forms Section 4.6, page 73 of the 2000 Guidebook	 	Details which members have and have not signed your contract enrollment foams, if needed.	 	Due immediately, if applicable
	Requirement 7: Sales representative Contact Information

Section 4.7, page 77 of the 2000 Guidebook	 	Able to update Sales Representative from a Business Partner Repository System downloads.	 	Due within 30 days of the Contract Effective Date information
	Requirement 8: Product Cross-referencing

Section 4.8, page 81 of the 2000 Guidebook	 	Must to update the items on contract with competitive cross-reference information	 	Due within 90 days of the Contract Effective Date
	Business Partner Repository System (BPRS) Access

Section 3, page 13 of the 2000 Guidebook	 	Able to connect to Novation BPRS via the VHAseCURE.netTM	 	Due within 60 days of the Contract Effective Date

1

  

 
 

EXHIBIT F
  
    NEOFORMA
  
    MASTER SUPPLIER AGREEMENT    
    

        This Master Supplier Agreement (the "Agreement") effective
                        ("Effective Date"), is entered into
by                        ,
a                        corporation having its principal place of business at
                        ("Supplier"), and Neoforma.com, Inc., a Delaware corporation having its principal
place of business at 3061 Zanker Road, San Jose, CA 95134 ("Neoforma"). 

        Neoforma provides e-commerce, auction, and other services to the healthcare industry, and  Supplier wishes to list its products and services through
Neoforma's e-commerce services and
to utilize certain other of Neoforma services. 

        Neoforma and Supplier therefore agree as follows: 

	1.
	DEFINITIONS

        1.1   "Acute Care Users" means either a short term care hospital in which the average length of patient stay is less than
thirty days, or a short-term care hospital in which over 50% of all patients are admitted to units where the average length of patient stay is less than thirty days. This includes those
hospitals operating as acute care facilities even if those hospitals provide such services as, for example, long term care, outpatient care, psychiatric care, or rehabilitative care, but shall exclude
facilities that are primarily nursing homes or primarily rehabilitation hospitals. 

        1.2   "Affiliate" means a person or entity controlled by or under common control with another person or entity. 

        1.3   "Content" means any text, graphics, logos, button icons, images, audio clips, HTML code, java programs and other material
displayed at the Marketplace. 

        1.4   "Contract Portfolio" means, with respect to a particular GPO, a catalog of Products for which the GPO has contracted with  Supplier for the benefit of the GPO's
Members. 

        1.5   "Fees" means all fees and other amounts paid by Supplier to  Neoforma in respect of the Services, as detailed
in the Schedules attached hereto. 

        1.6   "GPO" means an entity that meets the definition of a "Group Purchasing Organization" as set forth in 42 CFR
Section 1001.952(j). 

        1.7   "Information" means the information and data maintained and stored by  Neoforma, which shall include at a minimum (i) any and all information and data
collected, developed, and/or stored by Neoforma relating to Users
and (ii) any and all information and data relating to use of or transactions at the Marketplace by Users. 

        1.8   "Marketplace" means all Marketplaces as defined at Section 1.9 and all other portions of  www.Neoforma.com and other Neoforma web sites. 

        1.9   "Marketplace at [insert name of GPO]" means that portion of the Marketplace created specifically
for and accessible only to Members of a particular GPO. 

        1.10 "Members" means, with respect to a particular GPO, at any date, those organizations entitled to purchase Products at the
Marketplace of such GPO. 

        1.11 "Neoformat" means the format in which Product Data is to be sent to  Neoforma. 

        1.12 "Non-Contract Products" means any Product offered by  Supplier other than through a Contract Portfolio. For purposes of clarification, a Product may be offered by
 Supplier both as a NonContract 

1

 

Product
and through one or more Contract Portfolios, but will be considered a Non-Contract Product when purchased other than through the Contract Portfolio of a GPO. 

        1.13 "Products" means all equipment, products, supplies and services, information and content provided by  Supplier and available for purchase, rental, or lease by
Users at the Marketplace or through the Services. 

        1.14 "Product Data" means information describing the features, functions and pricing of  Supplier's Products including images to be offered at the Marketplace or
through the Services. 

        1.15 "Services" means the services provided by Neoforma to  Supplier the details of which, and fees for which are
specified in this Agreement and the Schedules attached hereto, which are agreed upon and signed by
authorized representatives of Supplier and Neoforma.  Supplier must comply with the
requirements and obligations detailed in these Schedules, and with the terms of this Agreement to use the Services.
 

        1.16 "Users" means all Members and other users of the Marketplace. 

	2.
	SERVICES

        2.1   Neoforma will provide the Services to Supplier, subject to the terms and
conditions of this Agreement and the applicable Schedules. 

	3.
	OWNERSHIP AND LICENSE

        3.1   Neoforma. Neoforma owns and will continue to own all Content, and the compilation or "look
and feel" of all Content subject to Section 14.1. Any reproduction, transmission, or display of the Content by Supplier or any third party is
strictly prohibited. 

        3.2   For
the term of this Agreement, Neoforma grants a non-exclusive, non-transferable, revocable
license to Supplier, without a right to sublicense, to access, and use the Services and the Marketplace in accordance with the terms of this Agreement. 

        3.3   Supplier. For the term of this Agreement, Supplier grants a
non-exclusive license to Neoforma to use, copy, modify, display, perform and create derivative works of  Supplier's Product Data solely for
the purpose of digitizing, categorizing and formatting such information for placement at the Marketplace, in
accordance with the terms of this Agreement and the Schedules attached hereto. 

	4.
	SUPPLIER'S PRODUCT DATA

        4.1   Supplier is solely responsible for all Product Data and any other Content it supplies to  Neoforma for inclusion at the Marketplace, including maintenance
of such Product Data and Content.  Neoforma will not be responsible for the accuracy or legality of information provided by Supplier for
publication at the Marketplace or through the Services, and Neoforma may at any time at its sole discretion, take any action with respect to such
information provided by Supplier, including removal from the Marketplace, and/or exercising its rights under Section 16.2, Termination, if  Neoforma reasonably believes that the information may cause liability for it. Product Data must not (a) infringe any third party rights,
including, but not limited to intellectual property, publicity or privacy, (b) be defamatory, trade libelous, threatening or harassing nor (c) be obscene, indecent or contain
pornography. 

        4.2.  Supplier shall make its Product Data available to Neoforma for listing
at the applicable Marketplace at [insert name of GPO] with respect to any Contract Portfolio Products and elsewhere at the Marketplace with respect to any
Non-Contract Products in accordance with the applicable Schedules hereto. 

        4.3   The
Product Data provided by Supplier shall include the specific terms and conditions of  Supplier's sale of Products to Users, subject to the
terms and conditions of any contract between 

2

 

 Supplier and a User or a GPO with respect to any Product (the "Supplier Terms and Conditions").  Neoforma does not set, approve, control, or endorse the Supplier Terms and Conditions. 

        4.4.  Supplier may update Product Data from time to time in accordance with  Neoforma's then current policies and procedures for accessing and updating Product
Data. Supplier will
update Product Data, including pricing information and the Supplier Terms and Conditions, as required to ensure that at all times such Product Data is
accurate, including removal of any discontinued or recalled Products. 

        4.5.  Neoforma will not be responsible for the fulfillment of or payments for orders for Products.  Supplier acknowledges that a User makes an offer for a
Product through the Marketplace when it places an order for such Product.  Supplier agrees to respond to an order for a Product within 24 hours of placement of such order by either accepting
or rejecting such order.  Supplier shall have the right, in its sole discretion, to accept or reject any order. Supplier
acknowledges that all orders made by Users for Products and accepted by Supplier will be accepted based on prices. and Product Data (including any
posted terms and conditions relating to purchase of such Products) as they appear at the Marketplace at the time of such order. Notwithstanding the foregoing, nothing in this Section 4.6 will
affect the Supplier's rights and obligations vis-a-vis the party placing the order. 

        4.6   Neoforma will not be responsible for ensuring that a sale to a User is authorized and in compliance with laws and that
User has complied with any licensing or other governmental requirements or for fulfillment, billing or collections to Users. Supplier shall provide
credential and licensure verification, fulfillment, billing and collections to Users who have purchased from the Marketplace. Supplier will have the
final authority to refuse to ship Products when it believes, in its sole discretion, that the party placing the order does not have the necessary license or other government required permission or
authority to receive the Product ordered or that such sale is otherwise not to an authorized User or not in compliance with applicable laws. Supplier
agrees to communicate to any such party the reasons for a refusal to ship an ordered Product. Notwithstanding the foregoing, nothing in this section 4.6 will affect the  Supplier's rights and
obligations vis-a-vis the party placing the order. 

        4.7.  Supplier shall be responsible for all customer support after the point when an order is made by a User and transmitted
from Neoforma to Supplier. 

	5.
	SYSTEM INTEGRITY

        5.1   Supplier will not use any software routine or any other device including but not limited to any viruses, Trojan horses,
worms, time bombs, or cancelbots, to interface or attempt to interfere with the proper working of the Marketplace. 

	6.
	FEES

        6.1   Supplier will pay Neoforma one hundred percent (100%) of the Fees (as
specified in the Schedules attached hereto) within thirty (30) days of the date of invoice by Neoforma. Overdue payments shall bear interest at
the lesser of twelve percent (12%) per annum or the maximum rate allowed under applicable law. All Fees specified herein are non-cancelable and non-refundable. All Fees are
payable in U.S. dollars and shall be sent to the attention of Neoforma's Accounts Receivable Department. 

	7.
	TAXES

        7.1   Supplier bears sole responsibility for payment and/or collection from Users of all local, state, national or foreign
taxes (including without limitation, sales, use, value added and other taxes which may apply), license, fees, export/import fees and any other similar obligations relating to any sale of a Product
listed at the Marketplace. In no event will Neoforma bear any such responsibility. 

	8.
	AUDIT RIGHTS

        8.1   Upon
reasonable prior notice to Supplier, Neoforma, at its own expense
may audit all relevant books and records of Supplier for the purpose of confirming compliance with this Agreement. Any examination shall be conducted
during Supplier's normal business hours, and will not unreasonably 

3

 

interfere
with Supplier's normal business. Such audits may not be conducted more than once in any six(6) month period. For purposes of conducting, such
audits, Neoforma may designate any party to act as its auditor, subject to Supplier's consent, which
shall not be unreasonably delayed or withheld. Supplier shall be deemed to have consented to the use of any nationally recognized accounting firm for
any such audit. 

	9.
	PRIVACY

        9.1   Supplier will have the ability to access that portion of the Marketplace which displays its Products, using a user ID and
password and otherwise in accordance with Neoforma's then current policies and procedures for accessing and updating Product Data. Such user IDs and
passwords should be maintained as confidential and should not be distributed or disclosed to third parties. It is Supplier's responsibility to notify  Neoforma of the need to change or discontinue the user ID or password. Such notification must come from an authorized officer of  Supplier. It is
Supplier's responsibility to discontinue any user IDs and passwords that are no longer
active. All personal contact information provided by Supplier's officers will be used in accordance with the terms of  Neoforma's privacy
policy. Supplier will review  Neoforma's privacy policy, which may be amended from time to time. If at any time Supplier is not in
compliance with this policy, then Neoforma has the right to terminate this Agreement and Supplier's
access to the Marketplace and ability to sell Products at the Marketplace as provided in Section 16.2 of this Agreement. 

	10.
	CONFIDENTIALITY

        10.1 Except
as expressly set forth in Neoforma's privacy policy, Neoforma,
and Supplier will regard and preserve as confidential all information related to the business of the other. Neither party will without first obtaining
the other party's prior written consent, disclose to any third party or use for its benefit any information relating to the business of the other party. This confidentiality obligation does not apply
to (a) information that is publicly known prior to the disclosure or becomes publicly known through no wrongful act of the receiving party; (b) information that was in lawful possession
of the receiving party prior to disclosure and was not received as a result of any breach of confidentiality; (c) information that was independently developed by the receiving party outside the
scope of this Agreement; or (d) information which the receiving party is required to disclose pursuant to a court order or regulatory agency request. In the event of a request for disclosure
pursuant to subsection (d), immediate notice of such request shall be provided by the other party in order to provide an opportunity to oppose such request for disclosure. Notwithstanding the
foregoing and except as otherwise limited, Neoforma shall be entitled to share (1) any and all Information in the aggregate relating to that
portion of the Marketplace created specifically for and accessible only to Members of a particular GPO with that particular GPO if Neoforma has entered
into an agreement to share such Information, and if not violative with any other agreement entered into by Neoforma, and (2) User specific
Information relating to that portion of the Marketplace created specifically for and accessible only to Members of a particular GPO with that particular GPO if  Neoforma has entered into an
agreement to share such Information, if not violative with any other agreement entered into by  Neoforma and if consented to by such User
 

	11.
	REPRESENTATIONS AND WARRANTIES

        11.1 Neoforma represents and warrants that (i) it has full power and authority to enter into this Agreement and the
applicable Schedules, (ii) it has all rights, titles, licenses, permissions and approvals necessary to perform its obligations under this Agreement and the applicable Schedules and to grant to  Supplier all licenses and rights granted hereunder, and that such licenses do not and will not infringe or otherwise violate any copyright, trade
secret, trademark, patent or other proprietary right of any third party, and (iii) that it has and will maintain the capability to provide the Services and to create and host the Marketplace
during the term of this Agreement and all applicable Schedules. 

        11.2 Supplier represents and warrants that (i) it has full power and authority to enter into this Agreement and the
applicable Schedules (ii), it has full power and authority to sell the Products to be 

4

 

sold
by it at the Marketplace and will not offer for sale counterfeit or stolen items, (iii) it is the sole owner or is a valid licensee of all Content provided by or on behalf of  Supplier for
inclusion at the Marketplace and has secured all necessary licenses, consents and authorizations with respect to use of such Content and
all elements thereof to the full extent contemplated herein, (iv) no part of any Content provided by or on behalf of Supplier for inclusion at
the Marketplace violates or infringes upon the patent rights, copyrights, trade secrets, trademarks or other proprietary rights of any person or entity or constitutes defamation, invasion of privacy
or the violation of the rights of any person or entity, (v) it has complied and shall continue to comply with all legislation, laws, statutes, ordinances, rules and regulations regarding the
Products and their sale or transfer, and its actions in relation to the Marketplace and the Services (including, without limitation, those governing medical devices, pharmaceuticals, export control,
consumer protection, unfair competition or false advertising), and (vi) it will not use the Marketplace to violate antitrust laws and will not use the Marketplace to engage in any price fixing
or enter into any agreement in restraint of trade. 

        11.3 EXCEPT
AS OTHERWISE SPECIFICALLY PROVIDED HEREIN, NEOFORMA SUPPLIES THE MARKETPLACE AND THE SERVICES "AS IS" AND WITHOUT
ANY WARRANTY OR CONDITION, EXPRESS OR IMPLIED. NEOFORMA SPECIFICALLY DISCLAIMS ANY AND ALL IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A
PARTICULAR PURPOSE, AND WARRANTIES ARISING FROM A COURSE OF DEALING, USAGE OR TRADE PRACTICE. NEOFORMA ALSO DOES NOT GUARANTEE CONTINUOUS, UNINTERRUPTED
ACCESS TO THE MARKETPLACE AND THE SERVICES, AND OPERATION OF THE MARKETPLACE MAY BE INTERFERED WITH BY NUMEROUS FACTORS OUTSIDE OF NEOFORMA'S CONTROL.
USE OF THE MARKETPLACE AND SALE OF PRODUCTS TO USERS IS AT SUPPLIER'S RISK. BY USING NEOFORMA'S SERVICES
AND THE MARKETPLACE, SUPPLIER REPRESENTS AND WARRANTS THAT IT CAN FORM LEGALLY BINDING CONTRACTS UNDER APPLICABLE LAW. FURTHERMORE,  SUPPLIER
REPRESENTS AND WARRANTS THAT THE INDIVIDUAL EXECUTING THIS AGREEMENT HAS AUTHORITY TO BIND
SUPPLIER AS SELLER AND THAT BY DOING SO IS NOT BREACHING OR IN CONFLICT WITH ANOTHER AGREEMENT OR OBLIGATION. 

	12.
	INDEMNIFICATION

        12.1 Subject
to Section 12.3, Neoforma will defend and/or handle at its own expense any third party claims or actions,
of actual or alleged infringement of a copyright, trade secret, trademark, patent or other proprietary right of a third party arising out of Supplier's
use of the Marketplace and the Services as permitted under this Agreement and the applicable Schedules, and shall indemnify and hold Supplier and its
respective officers and directors, harmless from and against any and all costs, and expenses (including reasonable attorney's fees) awarded against  Supplier arising out of such claim or action;'
and its settlement or compromise. 

        12.2 Subject
to Section 12.3, Supplier will defend, and/or handle at its own expense, any third-party claims or
actions, arising from (i) any breach by Supplier of any of its representations or obligations set forth in this Agreement and the applicable
Schedules (ii) any misrepresentation or omission in any Content provided by or on behalf of Supplier in connection with the Services or at the
Marketplace, (iii) any virus, worm, Trojan Horse or other contaminating or destructive feature containing any information or listing listed by  Supplier at the Marketplace, (iv) any
claims brought by a third party, having a basis in contract or tort, in law or in equity, relating to any
Products listed or sold by Supplier through the Marketplace or otherwise relating to Supplier's use of
the Marketplace or the Services, including but not limited to, interference with contract or prospective economic advantage, breach of contract, misrepresentation, gross negligence, products
liability, strict products liability or the failure to transfer good title to any products sold by Supplier at the Marketplace, and will indemnify and
hold harmless Neoforma, its Affiliates, and their respective officers and directors against any loss, liability, cost or expense (including reasonable
attorneys' fees) resulting from any such claim. Notwithstanding 

5

 

the
foregoing, as to any product liability claim Supplier additionally shall fully indemnify Neoforma
and shall cause Neoforma to be listed as an additional insured on any product liability insurance policy of  Supplier. 

        12.3 The
party seeking indemnification under subsection 12.1 or 12.2, as the case may be (the "Indemnified Party"), will give
prompt written notice to the other party (the "Indemnifying Party"). In addition, the Indemnified Party will allow the Indemnifying Party solely direct
the defense and settlement of any such claim, with counsel of the Indemnifying Party's choosing, and will provide the Indemnifying Party, at the Indemnifying Party's expense, with information and
assistance that is reasonably necessary for the defense and settlement of the claim. The Indemnified Party reserves the right to retain counsel, at the Indemnified Party's sole expense, to participate
in the defense of any such claim. The Indemnifying Party shall not settle any such claim or alleged claim without first obtaining the Indemnified Party's prior written consent, which consent shall not
be unreasonably withheld, if the terms of such settlement would adversely affect the Indemnified Party's rights under this Agreement and the applicable Schedules. 

        12.4 The
remedy provided under this Section 12 will be the Supplier's sole and exclusive remedies in relation to
claims and actions alleging intellectual property infringement. 

	13.
	LIMITATION OF LIABILITY

        13.1 WITH
THE EXCEPTION OF NEOFORMA'S OBLIGATIONS UNDER SECTION 12.1 IN NO EVENT WILL  NEOFORMA BE LIABLE TO SUPPLIER FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES
ARISING OUT OF THIS AGREEMENT OR THE SCHEDULES ATTACHED HERETO OR THEIR TERMINATION, WHETHER LIABILITY IS ASSERTED IN CONTRACT OR IN TORT, (INCLUDING NEGLIGENCE) AND IRRESPECTIVE OF WHETHER  NEOFORMA HAS BEEN ADVISED OF THE POSSIBILITY OF ANY SUCH LOSS OR DAMAGE. IN NO EVENT WILL NEOFORMA'S
TOTAL LIABILITY TO SUPPLIER OR TO ANY THIRD PARTIES, UNDER THIS AGREEMENT AND THE APPLICABLE SCHEDULES ATTACHED HERETO EXCEED THE AMOUNT OF FEES  SUPPLIER PAYS TO NEOFORMA IN THE 12 MONTHS PRIOR TO THE ACTION GIVING RISE TO THE LIABILITY. 

        13.2 NEOFORMA DOES NOT AND CANNOT CONTROL THE FLOW OF DATA TO OR FROM THE MARKETPLACE AND OTHER PORTIONS OF THE INTERNET.
ACTIONS OR INACTIONS OF THIRD PARTIES MAY RESULT IN SITUATIONS IN WHICH SUPPLIER'S CONNECTION TO THE INTERNET, AND/OR ACCESS TO THE MARKETPLACE MAY BE
IMPAIRED, DISRUPTED OR DAMAGED. NEOFORMA CANNOT GUARANTEE THAT SUCH EVENTS WILL NOT OCCUR, AND ACCORDINGLY DISCLAIMS ANY AND ALL LIABILITY RESULTING
FROM OR RELATED TO SUCH EVENTS. 

	14.
	INTELLECTUAL PROPERTY RIGHTS

        14.1 Each
party owns and shall retain all right, title to and interest in its names, logos, trademarks, service marks, trade dress, copyrights and proprietary technology,
including, without limitation, those names, logos, trademarks, service marks, trade dress, copyrights and proprietary technology currently used or which may be developed and/or used by it in the
future (the "Marks"). Neoforma is authorized to use  Supplier's Marks as necessary to
provide the Services under this Agreement. To the extent that Neoforma
modifies Product Data or other Content provided by Supplier pursuant to this Agreement and the applicable Schedules,  Supplier hereby
acknowledges that Neoforma will be the copyright owner of the derivative works that it
creates pursuant to and subject to the license granted in Section 3.3 (whether in graphical, narrative or any other form), and subject in all respects to  Supplier ownership of the underlying
information and to the copyright of third parties. 

6

 
	15.
	NO AGENCY; DISCLAIMER

        15.1 Supplier and Neoforma are independent contractors, and no agency,
partnership, broker-dealer, distributor, joint venture, employee-employer or franchiser-franchisee relationship is intended or created by this Agreement and the applicable Schedules.  Neoforma
provides a forum for buyers and Supplier to conduct transactions and is not involved in the
actual transaction between buyers and Supplier. Neoforma does not have any responsibility whatsoever
with regard to the actual fulfillment of any orders made by buyers, including but not limited to the shipment of the Products ordered or purchased at the Marketplace.  Neoforma has no control over
the price, contract terms, quality, safety, conformance or legality of the Products listed at the Marketplace, the truth or
accuracy of the listings, the ability of Supplier to sell items or the ability of buyers to buy items.  Neoforma has no control over whether
the offer or state of Products by Supplier or the purchase of
Products by a buyer is in compliance with applicable laws or whether Supplier or any buyer has any required license or other government permission or
authority for any such offer, sate or purchase. Neoforma cannot and does not control whether or not buyers will complete the purchase of items they have
ordered, and is not responsible for payment or collection of orders placed by User buyers at the Marketplace. NEOFORMA MAKES NO REPRESENTATIONS OR
WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED AS TO THE QUALITY, IDENTITY, OR CREDITWORTHINESS OF ANY BUYER. 

	16.
	TERM AND TERMINATION

        16.1 Term. The term of this Agreement will commence on the Effective Date and shall continue for a period of two
(2) years. This Agreement will automatically renew for additional one-year terms unless written notice of termination is provided by the terminating party to the
non-terminating party at least ninety (90) days prior to the expiration of the then-effective term. Unless otherwise indicated in the applicable Schedule, the term of
each Schedule hereto shall be the same as the term of this Agreement. 

        16.2 Termination. Either party will have the right to terminate this Agreement or any Schedule attached hereto in the event
of a material breach of the terms hereof or thereof by the other party which is not cured within thirty (30) calendar days following receipt of written notice specifying the breach. 

        16.3 Termination by Neoforma. In the event of excessive complaints to  Neoforma from Users about Supplier's compliance with the  Supplier Terms and Conditions or the service provided by Supplier
relating to Products  Neoforma may provide Supplier with notice of its receipt of such complaints and the opportunity to
respond to and cure the source of such complaints. If Supplier has not satisfactorily responded to or cured the source of such complaints within thirty
(30) calendar days following receipt of such notice, Neoforma, at its sole discretion will have the right to terminate this Agreement or any
Schedule attached hereto. 

        16.4 Schedules. Upon termination of this Agreement for any reason, all Schedules entered into pursuant to this Agreement
shall also terminate. 

	17.
	GENERAL PROVISIONS

        17.1 No Waiver. The failure of either party to require or enforce strict performance by the other party of any provision of
this Agreement or any Schedule hereto or to exercise any right under this Agreement or any Schedule hereto shall not be construed as a waiver or relinquishment to any extent of such party's right to
assert or rely upon any such provision or right in that or any other instance. 

        17.2 Entire Agreement. This Agreement and any applicable Schedule hereto represents the entire agreement, and supersedes any
and all prior agreements or understandings of the parties written or oral with respect to the subject matter hereof. This Agreement and the Schedules hereto may only be modified, or any rights under
it waived, by a written document executed by the duly authorized 

7

 

representative
of both parties. In the event of any conflicts or inconsistencies between the terms of this Agreement and any Schedules, the terms of the applicable Schedule will control. 

        17.3 Applicable Law; Jurisdiction. This Agreement and the Schedules hereto shall be interpreted, construed and enforced in
all respects in accordance with the laws of the State of California without reference to conflict of law principles. All actions brought by either party arising under or related to this Agreement or
any Schedules hereto shall be subject to the jurisdiction and venue of the state and federal courts located in Santa Clara County, California. 

        17.4 No Diversion. Supplier shall take all reasonable steps to insure that
buyers who purchase a Product as a result of selecting an item for purchase or quotation at the Marketplace execute their purchase of that Product at the Marketplace rather than through some other
means. 

        17.5 Non-Exclusivity. Supplier and  Neoforma agree that this Agreement and the Schedules hereto are non-exclusive
and that each party is free to contract and deal with
competitors of the other. 

        17.6 Assignment. This Agreement and the Schedules hereto shall not be assigned by either party without the prior written
consent of the other, except that no such consent will be required in connection with an acquisition, merger, reorganization or sale of all, or substantially all of either party's assets.  Neoforma may assign the Agreement and the Schedules hereto to an Affiliate of Neoforma. The parties further agree that an Affiliate of  Neoforma may provide services under this Agreement. Subject
to the foregoing, this Agreement will bind and inure to the benefit of the parties'
successors in title and permitted assigns. Any attempt to assign this Agreement other than as permitted above will be void. 

        17.7 Schedules. The Schedules applicable to this Agreement are attached hereto, refer explicitly to this Agreement, and are
dated and signed by both parties. 

        17.8 Notices. Any notice required or permitted by this Agreement shall be in writing and shall be deemed given if sent by
prepaid registered or certified United States mail, return receipt requested (if available), overnight mail with a nationally recognized overnight mail courier, or sent by facsimile or similar
communication, and confirmed by such mail, postage prepaid, addressed to the other party at the address shown below or at such other address for which such party gives notice hereunder. Notices will
be deemed given three (3) business days after deposit in the U.S. Mail, one (1) business day after 

8

 

deposit
with an overnight mail courier, or when confirmation of receipt is obtained if sent by facsimile or similar communication, as applicable. 

	 	 	If to Supplier:	 	 
	

 	
 	

	
 	

 
	

 	
 	

	
 	

 
	

 	
 	

	
 	

 
	

 	
 	

Facsimile:	

 	
 	

 
	 	 	 	
	 	 
	

 	
 	

Attention:	

 	
 	

 
	 	 	 	
	 	 
	

 	
 	

With a copy to:	
 	

 
	

 	
 	

	
 	

 
	

 	
 	

	
 	

 
	

 	
 	

	
 	

 
	

 	
 	

Facsimile:	

 	
 	

 
	 	 	 	
	 	 
	

 	
 	

Attention:	

 	
 	

 
	 	 	 	
	 	 
	

 	
 	

If to Neoforma:	
 	

 
	

 	
 	
Neoforma.com, Inc.

3061 Zanker Road

San Jose, CA 95134

Facsimile: (408) 468-4040

Attention: Chief Financial Officer	
 	

 

        17.9 Force Majeure. Neither party shall be considered in default in the performance of any obligation hereunder to the extent
that the performance of such obligation is prevented or delayed by fire, flood, explosion, strike, war, insurrection, embargo, government requirement, civil or military authority, act of God, failure
of the Internet or any other event, occurrence or condition which is not caused, in whole or in part, by that party, and which is beyond the reasonable control of that party. The parties shall take
all reasonable action to minimize the effects of any such event, occurrence, or condition. 

        17.10 Survival. The following sections will survive termination or expiration of this Agreement: 3.1, 6.1, 7.1, 8.1, 10.1,
11, 12, 13, 14.1, 15.1 and 17. 

        17.11 Execution in Counterparts, Facsimiles. This Agreement may be executed in one or more counterparts, each of which shall
be deemed an original and all of which together shall constitute one and the same instrument. This Agreement shall become binding when any one or more counterparts hereof, individually or taken
together, bear the signature of both Parties hereto. Novation may execute this Agreement by and on behalf of Neoforma, as  Neoforma's agent.
In such case Novation will not be responsible or liable for the obligations of  Neoforma or Supplier under this Agreement. For the 

9

 

purposes
hereof, a facsimile copy of this Agreement, including the signature pages hereto, shall be deemed an original. 

        IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 

	NEOFORMA.COM, INC.,

a Delaware corporation	 	SUPPLIER

a            corporation
	

By:	

	
 	

By:	

	

Title:	

	
 	

Title:	

	

Date:	

	
 	

Date:	

10

  

 
 

SUPPLIER SCHEDULE A2
  
    NOVATION CONTRACT PORTFOLIO PRODUCTS    
    

The following Schedule A2 to the Master Supplier Agreement by and between Neoforma.com, Inc. ("Neoforma") and
[            ]("Supplier") will apply to Products included in the Novation Contract Portfolio posted at the Marketplace with
right of access to the Novation Contract Portfolio (the Marketplace at Novation):

1.    Listing of Novation Contract Portfolio Products  

         1.1.  Supplier shall provide Neoforma with a list of all
Products that  Supplier offers through the Novation Contract Portfolio (the "Initial Novation Contract Portfolio. Catalog"). To the extent that Novation and
Supplier contract from time to time with respect to additional Products to be offered to Novation Members through the Novation Contract Portfolio,  Supplier will provide Neoforma with a list of such additional Products.  Supplier shall provide
Neoforma with the Product Data with respect to such Contract Portfolio Products
as is set forth in the NeoFormat specifications provided by Neoforma to Supplier from time to time (a
current copy of which has been provided to Supplier); provided that pricing information for Novation Contract Portfolio Products will be provided by
Novation and reviewed and approved by Supplier. Supplier and Novation shall provide such Product Data in
the manner and format set forth in such specifications. 

        1.2.  Neoforma shall digitize, categorize and format the Product Data for the Initial Novation Contract Portfolio Catalog and
post such Product Data at the Marketplace at Novation in accordance with Neoforma's standard practices for digitization, categorization, and formatting
of Product Data. Neoforma shall digitize, categorize, format, and post Product Data for additional Novation Contract Portfolio Products offered by  Supplier from time to time in accordance with Neoforma's then-current standard practices.
 

        1.3.  Supplier acknowledges that Novation shall have the right to review all Product Data with respect to Novation Contract
Portfolio Products prior to the posting of such Product Data at the Marketplace at Novation. 

        1.4.  Supplier agrees that, notwithstanding Section 4.4 of the Master Supplier Agreement, it shall not revise pricing
information with respect to Novation Contract Portfolio Products without the prior approval of Novation. Suppliers are required to provide thirty
(30) days written notification to Novation in advance of any price changes of Novation Contract Portfolio Products posted at the Marketplace at Novation. 

        1.5.  Supplier agrees to pay the fees for digitization, categorization, formatting and posting of Product Data for Novation
Contract Portfolio Products set forth in the following table. 

	Service
 
	 	Quantity
	 	Fee ($)

	Digitizing, Categorizing & Displaying Supplier's Products included in the Novation Contract Portfolio at the Marketplace at Novation.	 	 	 	 
	 	Manual format	 	 	 	Per item
	 	Digital format	 	 	 	Per item
	Updating	 	 	 	 
	Maintenance	 	 	 	 

Neoforma agrees that, to the extent a Product is offered at the Marketplace as a Non-Contract Product or through the Contract Portfolio of a
GPO other than Novation in addition to through the Novation Contract Portfolio, Supplier will only be required to pay once for the digitization,
categorization, formatting and posting of such Product. 

1

 

2.    Transaction Fees for Novation Contract Portfolio Products. Supplier agrees to pay to  Neoforma transaction fees for the sale of Products through the Novation Contract Portfolio at the Marketplace at Novation as set forth in the following
table. 

	Transaction
 
	 	Fee per transaction ($)

	 	Purchase of Products distributed but not manufactured by Supplier through the Novation Contract Portfolio at the Marketplace at Novation or purchase of such Products
through the Novation Contract Portfolio after quote is requested at the Marketplace at Novation.	 	[    ]% per [    ]
	 	Purchase of Products manufactured and distributed by Supplier through the Novation Contract Portfolio at the Marketplace at Novation or purchase of such Products
through the Novation Contract Portfolio after quote is requested at the Marketplace at Novation.	 	[    ]% per [    ]
	 	Purchase of Products manufactured but not distributed by Supplier through the Novation Contract Portfolio at the Marketplace at Novation or purchase of such Products
through the Novation Contract Portfolio after quote is requested at the Marketplace at Novation.	 	[    ]% per [    ]

3.    Non-Acute Care Users. Supplier acknowledges that the aforementioned transaction fees for Products
through the Novation Contract Portfolio contemplate sales of Products to Acute Care Users. Supplier further acknowledges that  Neoforma is
contemplating a separate arrangement, including with respect to transaction fees, for Non-Acute Care Users, whether through
development of a separate Marketplace or otherwise (the "Non-Acute Arrangement"). The parties agree that, at such time as Neoforma shall
have developed the Non-Acute Arrangement, the parties will negotiate in good faith to agree to a schedule, including setting transaction fees to be paid, addressing the
Non-Acute Arrangement. If the parties are unable to reach agreement with respect to the Non-Acute Arrangement, Neoforma shall be
entitled to limit Supplier's sales of Products through the Novation Contract Portfolio through the Marketplace to Acute Care Users. 

4.    No Agreement with Manufacturer. Neoforma expressly reserves the right not to post any NonContract Product at the
Marketplace and to remove any such Product from the Marketplace in the event Neoforma does not have an agreement with the manufacturer of such Product
for the payment of transaction fees on sales of that Product at the Marketplace. 

	ACCEPTED BY:	 	ACCEPTED BY:
	
SUPPLIER	
 	

NEOFORMA.COM, INC.
	

 Authorized Signature	
 	

 Authorized Signature
	

 Printed Name and Title	
 	

 Printed Name and Title
	

 Date	
 	

 Date

2

  

 
 

SCHEDULE C
  
    (MANUFACTURER AND DISTRIBUTOR)
  
    NEOFORMA STATEMENT OF WORK FOR CONNECTIVITY    
    

The following Schedule C to the Master Supplier Agreement by and between Neoforma.com, Inc. ("Neoforma") and
[                        ]("Supplier") describes the services
available to Supplier in
support of Supplier's connectivity with the Marketplace:

Neoforma and Supplier will agree to a statement of work and professional services agreement ("Statement
of Work") with respect to any professional services required for establishing connectivity between Supplier and the Marketplace, which Statement of Work
will be attached hereto. Neoforma agrees to waive its hourly rate for the first 80 person-hours of any such professional services provided to  Supplier for establishing such connectivity. Rates for additional services will be as set forth in the Statement of Work. 

	ACCEPTED BY:	 	ACCEPTED BY:
	
SUPPLIER	
 	

NEOFORMA.COM, INC.
	

 Authorized Signature	
 	

 Authorized Signature
	

 Printed Name and Title	
 	

 Printed Name and Title
	

 Date	
 	

 Date

1

  

 
 

NOVATION—WOUND MANAGEMENT PROGRAM
  INVITATION TO BID (ITB)
  THERAPEUTIC SPECIALTY BEDS, THERAPEUTIC SURFACES, & RELATED
  PRODUCTS
  AGREEMENT TERM: Five Years Initial Term Beginning
September 1, 2001    
    

 
  EXHIBIT H—EXCEPTIONS TO THE SUPPLIER AGREEMENT
  SUPPLIER AGREEMENT—PROPOSED EXCEPTION FORM    
    

	Supplier Name	 	 
	

KCI USA Inc.
	
 	

 
	

Printed Name	
 	

 
	

Scott Brooks
 Authorized Signature	
 	

 
	

Title Vice President, National
Accounts                                        
                    Date April 5, 2001
	
 	

 

	
Page #
 
	
 	

Para #
	
 	

Define Exception Being Taken

	
 	
 	

 	
 	

 
	

2	
 	

2b	
 	
Add: "; unless the Member purchases products under the terms of an agreement with another group purchasing organization" at the end of the first sentence ending
with....Section 7 and 9 below.
	

or 2	
 	

2d	
 	

Pricing for the V.A.C and related accessories and DriFlo Products shall be protected until August 31, 2002,.." at the end of the paragraph.
	

3	
 	

2g

Need to have Marketplace signed.	
 	

Add "KCI USA agrees to participate in the Marketplace@Novation subject to agreement of the final terms and conditions of Exhibit F and any schedules or attachments after good faith negotiations by and between Neofroma.com, Inc. and KCI USA.
The Neoforma Master Supply Agreement and all attachments, as it relates to Product lines offered for purchase only (not rental), shall be finalized within forty-five (45) days of any Novation contract extension award."
in second sentence after the word...comply.

Exceptions to the Supplier Schedule A2:

Add: Schedule A2 is subject to agreement of the parties regarding product lines to be offered through Marketplace@Novation. The Neoforma Master Supply Agreement and all attachments, as it relates to Product lines offered for
purchase only (not rental), shall be finalized within forty-five (45) days of any Novation contract extension award.

Add: Supplier Schedule A2 is subject to the agreement of the parties as to fees in section 1.5 and 2 and/or fee waivers.

Supplier Schedule A2 is subject to final agreement of the items and conditions contained in Exhibit F-Neoforma Master Supply Agreement after good faith negotiations by and between Neofroma.com Inc. and KCI USA. The Neoforma
Master Supply Agreement and all attachments, as it relates to Product lines offered for purchase only (not rental), shall be finalized within forty-five (45) days of any Novation contract extension award.

Per phone call with C. Fashek on 4-17 the parties agreed to work in good faith to add rental transactions on the Marketplace@Novation. Details to be worked out [text illegible]
	

3 NEW	
 	

3b 3c	
 	

Change written notice for Novation and Supplier to "one hundred twenty (120) days for termination for any reason.
	

3	
 	

3b-1	
 	
Strike "(1) Supplier breaches this Agreement; or "and substitute" (1) Supplier commits a breach of this Agreement and fails to cure such breach within 30 days of being notified of the breach,
 except for Supplier's monetary breach or breach of Compliance with Laws for which a cure period shall not be allowed."
	 	 	 	 	 

1

 

	

4	
 	

4a	
 	
Strike the first three sentences and substitute "On and after the Effective Date, Supplier agrees to deliver rental products ordered by the Members to the Members, FOB destination, and shall
direct its invoices to the Members in accordance with this Agreement. Purchase products will be shipped F.O.B. Origin, freight prepaid and added to invoice. Rental and purchase products payment terms will be 2% 15 days, Net 30 days."
	

4	
 	

4b	
 	
Strike second sentence and replace with "Supplier will provide E-mail confirmation of orders for medical device purchased products greater than $500.00 from Members within two business days
and provide expected delivery time within five (5) business days after placement of the order.
	

6	
 	

5d	
 	
Insert "non-rental, after "order, all" in the first sentence
	

8	
 	

7a2	
 	
Insert "and rentals" after...net sales in all cases in section 7a2. add "unless the Member
purchases products under the terms of an agreement with another group purchasing organization" to the end of section 7a2 paragraph.
	

9	
 	

7a3	
 	
Insert "and rentals" after...net sales.
	

10	
 	

9a	
 	
Change the first sentence to "Supplier will pay to Novation, as the authorized collection agent for the Clients, marketing fees ("Marketing Fees") belonging to the Clients equal to the
Agreed Percentage of the aggregate gross charges of all net sales and rentals of the Products by the Members directly or indirectly from Supplier, whether under the pricing and other terms of this Agreement or under the terms of any other purchasing
or pricing arrangements that may exist between the Members and Supplier; unless the Member purchases products under the terms of an agreement with another group purchasing organization."
	

10	
 	

9b	
 	
Strike the first paragraph insert "No later than the twentieth (20th) day of each month, Supplier shall remit the monthly Marketing Fee for the preceding month to Novation. Supplier shall
pay Marketing Fees by check made payable to "Novation, LLC." All checks should reference the Agreement number. Supplier shall send by first class mail shall be mailed to the following address:

Novation

Remittance Dr., Suite 1420

Chicago, IL 60675-1420"

	

1 3	
 	

14	
 	
Insert "provided by supplier" after... indemnify, in clause number 3
	

14	
 	

17a	
 	
Strike "supplier" and substitute "Each party" before...Agrees, in
clause a.
	

14	
 	

17a1	
 	
Strike "Novation the Clients and the Members" and substitute "the other party (which, in the case of Novation shall include the Clients and the
Members)."
	

14	
 	

17a2, 17a3, 17a4	
 	
Strike "Novation" and substitute "the other party" in each sentence.
	

14	
 	

17b	
 	

Strike "Novation, the clients and the Members" and replace with "the parties", insert "Supplier" before Novation in the first sentence. Strike
"Supplier" and replace with "party", strike "it charges the members for products ordered and replace with
"charged" and strike Novation and replace with "the other party" in the second sentence.
	

14	
 	

17c	
 	

Notwithstanding the above provisions, Novation may disclose to Neoforma.com, Inc. the pricing and other terms of this Agreement for use by the Members of the Marketplace@Novation.
	

15	
 	

18d	
 	
Add "KCI USA Inc.

Attn: General Counsel

8023 Vantage drive

San Antonio, Texas 78230"
	

Exhibit E	
 	

Page 2 3a	
 	
Strike "No" replace with "all", insert "electronically transmitted" before Document.

2

QuickLinks

Exhibit 10.25

EXHIBIT A PRODUCT AND SERVICE DESCRIPTION AND PRICING

Exhibit A-Line Item Award Pricing NOVATION L.L.C. KCI USA Inc. THERAPEUTIC SUPPORT SURFACES AND OVERLAYS LEVEL I PRICING—90% COMPLIANCE—COMMITTED DOLLAR VOLUME = $0-99,999

Attachment #2 to Exhibit A LETTER OF PARTICIPATION WITH KCI USA, INC.

Attachment 3 to Exhibit A Novation EXPENSE CAPs As of February 28, 2001

EXHIBIT B NON-PRICE SPECIFICATIONS

Attachment 1 to Exhibit B Sheet & Cushion Service Agreement

Extended Warranty Agreement

Product Maintenance Agreement

EXHIBIT C SPECIAL CONDITIONS

Attachment 1 to Exhibit C OPPORTUNITY-COMPLIANT KCI LIST

EXHIBIT E OTHER INFORMATION REQUIREMENTS

Novation Electronic Communication Requirements Schedule

EXHIBIT F NEOFORMA MASTER SUPPLIER AGREEMENT

SUPPLIER SCHEDULE A2 NOVATION CONTRACT PORTFOLIO PRODUCTS

SCHEDULE C (MANUFACTURER AND DISTRIBUTOR) NEOFORMA STATEMENT OF WORK FOR CONNECTIVITY

NOVATION—WOUND MANAGEMENT PROGRAM INVITATION TO BID (ITB) THERAPEUTIC SPECIALTY BEDS, THERAPEUTIC SURFACES, & RELATED PRODUCTS AGREEMENT TERM: Five Years Initial Term Beginning September 1,
2001

EXHIBIT H—EXCEPTIONS TO THE SUPPLIER AGREEMENT SUPPLIER AGREEMENT—PROPOSED EXCEPTION FORMQuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.28    
    

 
 

AVAIL MEDICAL PRODUCTS, INC. & KINETIC CONCEPTS, INC.
  AMENDED AND RESTATED
  MANUFACTURING AGREEMENT    
    

        This Amended and Restated Manufacturing Agreement (this "Agreement") is made and entered into as of the 18th day of December, 2002, by and between Kinetic
Concepts, Inc., a Texas corporation having an address of 8023 Vantage Drive, San Antonio, TX 78230 ("KCI") and Avail Medical Products, Inc., a Delaware corporation with principal offices
at 201 Main Street, Suite 1660, Fort Worth, Texas 76102 ("Avail"). It is understood that this Agreement will inure to the benefit of all subsidiaries and affiliates of KCI, as well as KCI
(collectively, the "KCI Affiliates") and will be effective as of October 1, 2002 (the "Effective Date"). 

W I T N E S S E T H  

        WHEREAS, the KCI Affiliates wish to purchase high quality V.A.C. disposables and related items from Avail while
obtaining significant price breaks, and Avail wishes to manufacture and sell such products to KCI in accordance with the terms of this Agreement; and 

        WHEREAS,
KCI and Avail entered into a Manufacturing Agreement on September 21, 1999 and now wish to amend and restate that Agreement; 

        WHEREAS,
KCI and Avail each recognize new circumstances in terms of opportunity and need relating to the subject of that September 21, 1999 agreement between the Parties, and
intend to extend the material benefits of that agreement beyond its original term; 

        NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the
sufficiency of which is hereby acknowledged, it is agreed by
and between KCI and Avail (collectively, the "Parties"), for the mutual benefit of Avail and the KCI Affiliates, as follows: 

        1.    Definitions.    It is understood that words and phrases set out in quotation marks in this Agreement (often
within parentheses) constitute defined terms. Absent a very clear expression otherwise, the definitions of defined terms of this Agreement shall be consistent for all purposes of this Agreement,
irrespective of whether inconsistent definitions are given for the same or similar terms in other documents. The term "includes" (and conjugates thereof) shall always be understood to mean "includes,
without limitation," (or the like) unless expressly stated otherwise herein. 

        2.    Products.    The term "Products" in this Agreement shall mean all sterile disposable products for use with
vacuum assisted wound closure therapy currently being marketed by KCI or under current development by KCI in cooperation with Avail. The current Products are listed on Exhibit "A". The Products shall
not include any new products that are substantially different from the current Products (i) in terms of materials or manufacturing processes used or (ii) because they assist in the
delivery of vacuum assisted therapy together with other different therapies. Upon agreement between the Parties, other products will be added to Exhibit "A" (together with any pricing or other
information that may be necessary) and shall become Products upon the mutual agreement of the Parties. Even without amending Exhibit "A", in the event Avail undertakes manufacture of other products
for KCI, such other products shall be presumed to be treated as Products under this Agreement, although they shall not be treated as Exclusive Products unless such treatment is expressly agreed by
KCI. 

        3.    Exclusivity Period.    The Parties acknowledge that this Agreement provides for certain exclusivity between
certain Parties throughout the Exclusivity Period. The "Exclusivity Period" shall be the period of time commencing as of the Effective Date set forth herein and, unless this Agreement is sooner
terminated or converted with cause, ceasing [***] thereafter. The Exclusivity Period shall be extended each time the term of this Agreement is extended in accordance with
Section 20. In the event this Agreement is terminated or converted to a non-exclusive agreement for cause during the 

 

Exclusivity
Period, then the Exclusivity Period shall immediately cease as of such termination or conversion. 

        4.    Exclusivity Terms.    Absent a contrary agreement, [***] shall be deemed "Exclusive
Products", provided, however, in the event KCI develops products which (i) are substantially different from the current Products in terms of materials or manufacturing processes used, or
(ii) deliver [***] together with other different therapies, such KCI products shall not
be Exclusive Products without express agreement by KCI to that effect. In the spirit of goodwill and co-operation contemplated by this Agreement, KCI agrees to disclose to Avail such
products and the manufacturing plans for them prior to marketing launch of such products. Throughout the Exclusivity Period and thereafter for a period of thirty-six months, Avail agrees
to not manufacture or sell any products or components that are either adapted for, or reasonably likely to be used in, vacuum assisted wound closure therapy ("Similar Products") to or for any customer
other than the KCI Affiliates. Moreover, Avail agrees that each of its managerial, supervisory, development or engineering employees involved in the manufacture of Products will execute an agreement
not to be involved in the production or distribution of Similar Products during the Exclusivity Period and for a period of thirty-six months thereafter unless this agreement is terminated
by Avail as a result of an Event of Default or this Agreement is terminated by KCI without cause in which case such period shall be twelve months.. Throughout the Exclusivity Period, KCI likewise
agrees to purchase all of its quantities of Exclusive Products for domestic sale (i.e., within the continental United States) from Avail. Notwithstanding the preceding, KCI International, Inc.,
together with its wholly- or partially-owned subsidiaries, divisions and the like, (collectively, "KCII") shall have the right to manufacture and commercialize the Products, and to contract with third
parties to manufacture and commercialize the Products, independent of Avail; provided, however, in the event that Avail has established a fulfillment center in Europe capable of meeting the
international demand for KCI's VAC disposables by June 30, 2003, KCI agrees to purchase all of its quantities of Exclusive Products for domestic and international sale from Avail, for the term
of the Agreement. The foregoing notwithstanding, KCI shall retain the right to manufacture Products in an amount not to exceed one (1%) percent of its annual needs which shall be used for product or
process development purposes; provided, however, that KCI agrees that the Products that are manufactured by them for these purposes may only be distributed by Avail consistent with the terms of this
Agreement, at a transfer price which will be negotiated by the parties in good faith. 

        5.    Purchase and Sale.    The KCI Affiliates agree to purchase, from Avail, Products in quantities to be specified
by the KCI Affiliates. Avail agrees to sell Products to KCI Affiliates, agrees to drop-ship such sold Products to the designated customers of the KCI Affiliates in such manner as may be
requested by the KCI Affiliates or their customers, and agrees to thereafter promptly notify the KCI Affiliates with confirmation that such Products have been properly shipped by Avail to the
corresponding customer in the manner requested. 

        6.    Order Processing.    Although the mechanics of purchase and sale under this Agreement may change by mutual
consent over time, it is initially agreed that: (i) KCI Affiliates shall provide Avail with 12-month forecasts of its expected requirements (i.e., expected quantities needed) for
the Products in order to enable Avail to forecast production requirements, and KCI shall update such forecasts upon Avail's request (expected to be requested on a quarterly basis); (ii) orders
(or "pick release") for product shipment ("Sales Orders") shall be initiated by or under the direction of the KCI Affiliates by means of a computerized system that will be networked between Avail and
one or more of the KCI Affiliates; (iii) upon initiation of a Sales Order within the networked system, Avail shall thereupon ship the ordered Products as instructed; (iv) promptly upon
shipment of the ordered Products, Avail shall confirm such shipment by means of entering a ship confirmation in the networked system; and (v) Avail shall periodically invoice the respective KCI
Affiliates for payment of the agreed price for all Products shipped in a given billing period. 

2

 

        7.    Stock Levels.    Avail agrees to maintain an adequate supply (based on purchase orders, forecasts and
then-current historical information) of all Products (finished goods ready for immediate shipment) at all times. The Parties will also work together in good faith to determine other
measures for maintaining appropriate stock levels based on historical information and marketing projections. Avail will maintain adequate inventory levels on all Products for immediate shipment of
reasonably forecasted quantities, with a reasonable added safety stock. For USA stocks, the 3-5-7 Week Stock Replenishment Rules currently in place constitute adequate stock.
The parties agree that following an initial stocking level of 8 weeks of usage, similar replenishment rules will be developed and implemented for KCII stock, adjusted from the USA rules to allow for
transportation time. 

        8.    Shipment.    Upon receipt of a Sales Order pursuant to a blanket purchase order under this Agreement, Avail
agrees to timely drop ship all the Products so ordered to the site(s) designated in the Sales Order, in the manner indicated in the Sales Order or (if not so indicated) in such other manner as may be
customary between the Parties. For shipments within the USA, the term "Same-Day Deadline" shall mean three o'clock p.m., Pacific Standard Time, or such other reasonable deadline
time as may be agreed in writing between the Parties. All Products for which a Sales Order is entered into the networked system and received by Avail prior to the Same-Day Deadline on any
given business day shall be shipped that same day by Avail, in the manner required. If, on the other hand, a Sales Order is not entered into the networked system until after the Same-Day
Deadline on any given business day, Avail shall not be required to ship the corresponding Products until the next business day. Avail shall not confirm shipment of any Products until shipment has
actually occurred. Terms of shipment for KCII shipments will be agreed to by both parties prior to initiating shipments from the European fulfillment center. Each shipment confirmation shall contain
or refer to such information as may be required and as may be appropriate for such confirmation to meet the needs of the KCI Affiliates. A KCI Affiliate shall be responsible for freight expenses for
Products sent out-bound from Avail to KCI customers pursuant to a Sales Order. In the event the terms of a purchase order or sales order are not in accordance with any provisions of this
Agreement and Avail has not so notified the respective KCI Affiliate of the nonconformance by the Same-Day Deadline on the next business day following Avail's receipt of such an order,
then the terms of such order shall be deemed accepted by Avail. Avail shall do all things reasonably required to facilitate processing of purchase orders, shipments, invoices and confirmations in such
manner as may be requested by the KCI Affiliate which submits a Sales Order. KCI has the responsibility to pay any local taxes, including VAT in Europe, on the Products it purchases from Avail when
such taxes relate to the transfer of title for the Products. 

        9.    Delivery; Remedies.    Consistent and predictable on-time delivery of the products by Avail to KCI's
customers and affiliates is of fundamental importance to this Agreement. The parties have and will continue to establish mechanisms to provide for minimum levels of finished goods inventory for the
Products to be held by Avail both in the United States, Europe and other locations as may become necessary from time to time. It is the expectation of the parties that on-time delivery
performance by Avail will continue at the same level as has been experienced in the past. The methods of assuring continued levels of service will include the following: 

	a.
	Minimum
levels of inventory maintained at locations as agreed by the parties;

	b.
	Prior
notice of any future product shortages which occur because of problems in the supply chain, quality of incoming raw materials, and changes to product specifications within
seventy-two (72) hours of identifying an issue which in its judgment is likely to lead to a product shortage, regardless of when that product shortage is likely to occur, Avail will
notify KCI. 

3

 

        The
methods by which acceptable levels of service will be measured and by which corrective action may be implemented to improve deficiencies are as follows: 

	a.
	Avail's
historical service levels shall serve as a baseline for measurement, as reported. The Parties will agree on a "Shipping Performance Report" and an "Inventory Level Report",
similar to current reports on these activities, to be published monthly by Avail and agreed to by KCI. A rolling six-month average of performance levels published in the Shipping
Performance Report and the Inventory Level Report will be used as the basis against which changes from historical service levels will be determined.

	b.
	Should
circumstances arise where KCI believes that there has been a non-temporary change in Avail's ability to continue to meet its historical service levels, KCI may
request a meeting to discuss its concerns and if it is not satisfied that the issues are of a non-temporary or correctable nature may provide notice of ninety (90) day cure period
as set forth above. 

        The
provisions of this Agreement regarding the time within which Avail must deliver the Products are of the essence. If a Sales Order is within forecasted quantities and Avail fails to
timely ship the ordered Products within [***] of the time required herein for shipping, then KCI shall receive a [***] discount on price for such
Product. KCI shall also receive [***] discount for [***] the Product is late being shipped, although such discounts shall not exceed an aggregate
maximum discount of ten percent. The terms and conditions set forth in this section are in addition to and not in lieu of all rights and remedies otherwise provided by law. Notwithstanding the above,
shipments from Avail's European distribution center will be exempted from the above standards and remedies through December 31, 2003 so as to allow the parties to develop historical fulfillment
patterns. Avail will use commercially reasonable best efforts to fulfill all KCII orders on a timely basis during this initial period. 

        10.    Pricing.    All Products will be sold by Avail to KCI at the prices listed in Exhibit "A" (and permitted
modifications thereof). [***] For a period of one (1) year after any termination of this Agreement, Avail shall supply Products to KCI at the pricing in effect as of
termination, subject to changes permitted above. Thereafter, the pricing will be subject to change, to the extent encouraged and permitted in this Agreement. The pricing for any products added to
Exhibit "A" after the Effective Date shall be negotiated in good faith by the parties, based upon commercially reasonable markups of the cost of purchased components, raw material and labor. The
parties agree that KCI may reopen the price negotiations if a product competitive to any Product is introduced by a KCI competitor. 

        11.    Price Reductions.    At least annually, pricing of Products will be reviewed for opportunities to reduce prices
resulting from changes to design, materials, manufacturing processes, production volumes, and market conditions. The pricing review will be mutually undertaken in accordance with Section 21 of
this Agreement. Also, with the exception of the Freedom Canister, [***]. Upon conclusion of this analysis [***]. Based upon Avail's current estimate and
the 2003 forecast, KCI's share of the annual savings under this proposal would be $[***]—$[***]. KCI and Avail agree together that, after
execution of this Agreement, they will pursue the available options for manufacture in a low labor cost environment in a manner that is diligent and respects the interests of both parties. 

        12.    Logistics.    As the exclusive worldwide supplier of VAC disposables, Avail will promptly undertake to
establish a product fulfillment capability in Europe. Product pricing for Europe will include this service. Consistent with the U.S. model, KCI will be responsible for freight costs from the
fulfillment center to the end user (KCI's customer). KCI agrees that the process leading to the manufacturing of all Products by Avail can be concluded no later than June 30, 2003. Avail's
facility in Santa Ana, California will be the primary site of manufacture for VAC disposable products initially. It is part of Avail's current business plan to establish a new manufacturing facility
in Europe which will support KCI Europe. Avail will also initiate development of a disaster recovery plan (the "Plan") which will provide for dual sourcing for molded parts, sub- and final
assembly and all Quality Assurance functions within another Avail facility. Development of the Plan, which will in part be dependent upon 

4

 

a
survey of tooling and the supply chain in Europe, will commence within forty-five (45) days of execution of this Agreement and will be complete within ninety (90) days of
the execution of this Agreement. Preparation of the Plan is expected to be simultaneous with changes in Avail's UK manufacturing base operations and/or development of a new or additional manufacturing
site within Avail. 

        13.    Other Consideration.    [***] 

        14.    Payment.    KCI (or its appropriate Affiliate) shall pay the purchase price for the Avail Products within
thirty (30) days of the date of invoice. For shipments within the U.S., invoices shall be delivered promptly to Kinetic Concepts, Inc., 4958 Stout Drive, San Antonio, Texas 78219 or to
such other address as may be designated by KCI. Invoicing and payment methods for KCI will be agreed to by both parties prior to initiating shipments from the European fulfillment center. 

        15.    Product Quality.    Each Product shipped by Avail will meet the specifications reflected in the device master
record that corresponds to the part number for that Product as of the date on which the Product is manufactured. The Products and their specifications
may be expanded or otherwise modified in writing upon mutual agreement of the Parties. Avail shall provide customary product warranties as may be reasonably agreed between the parties. Avail shall
manufacture the Products so as to meet such specifications and shall include in each Product's labeling all warnings and instructions specified by KCI. Any changes that affect the performance of any
Products shall not be made without advance written consent of KCI. In the event that changes are required to correct defects in the Products, to enhance the safety or the Products, or to otherwise
improve the quality of the Products, Avail shall provide KCI with notice of the same promptly upon Avail's recognition of the need for the same, and the Parties shall mutually agree to any such
changes and the appropriate validation for such changes. All specification changes, including changes in quality control and manufacturing processes, shall be validated and documented by Avail. No
non-conforming Products will be released to KCI Affiliates, or their customers, without the prior written approval of KCI. Product specifications, which shall be documented in the device
master record, shall not be changed by Avail absent express authorization from KCI. 

        The
parties will work together to develop a Quality Plan or Plans applicable to the Products outlining the responsibilities and expectations of the parties regarding Quality and Service
Performance Levels for the products. Such quality plans, which may be amended by the parties from time to time, shall be consistent with the requirements of the Quality System Regulations and European
Medical Device Directives, and shall be of a form and complexity consistent with customary industry standards. The Quality Plan or Plans shall be considered integral to this Agreement and the
responsibilities of each party under this Agreement with respect to quality concerns. 

        The
basis for Quality Levels for all of the products shall be the Quality confidence level established through the FMEA, completed in the design and process verification and validation
activities for each of the products. It is expected that the products, given their complexity and regulatory classification status, will have applicable to each of them a 95% confidence level that
they are free of defects in workmanship and material. Such confidence levels shall be effected specifically by the activities and responsibilities identified in paragraph 23 of this Agreement. 

        It
is the expectation of the parties entering this Agreement that the Quality and Service levels to be provided by Avail going forward shall be consistent with those provided by Avail in
the past. The Parties will agree upon a "Quality Performance Report", similar to current quality reports, to be published monthly by Avail and in a format acceptable to KCI. A rolling
six-month average of performance levels published in the Quality Performance Report will be used as the basis for measuring changes in Avail's historic quality performance levels. The
parties will cooperate fully in amending and updating performance levels and expectations to assure that KCI and the products continue to meet and exceed the customary Quality and Service expectations
of the market. Should complaints or other 

5

 

forms
of negative quality events occur at a level or frequency that causes concern to KCI and are inconsistent with or different from the historical performance levels of Avail, KCI may request an
inspection and meeting as contemplated in Section 17 of this Agreement. It will then be the right of KCI to examine all manufacturing and quality related documentation to assure that Avail is
consistently following the procedures established during the verification and validation processes to meet product quality expectations. To the degree that Avail is failing to materially conduct such
activities as set out above, KCI may provide notice to Avail of such facts and provide for the ninety (90) day cure period as contemplated elsewhere in this Agreement. 

        16.    Packaging and Labeling.    Avail shall apply logos and shall label and package the Products in accordance with
KCI specifications. Avail shall be responsible for manufacturing the Products in accordance with KCI specifications. Avail will ship all Products under KCI's name. KCI shall notify Avail of any known
damage to the Products within five (5) business days of KCI's actual knowledge of such damage, and Avail shall provide replacements for damaged Products if damage is caused by failure to meet
KCI specifications. Absent contrary written instruction by KCI, the labeling for any and all Products made by Avail for KCI Affiliates (i) shall bear such trademarks, logos and source
identifiers as may be instructed by KCI ("KCI Trademarks"); (ii) shall bear such notices as may be required by KCI or applicable laws and regulations; (iii) shall bear the designation
"MADE FOR KINETIC CONCEPTS, INC, SAN ANTONIO, TX"; and (iv) shall not reference Avail. Nothing herein, nor any performance hereunder, shall be construed as a license for Avail to use the KCI
Trademarks in any manner not expressly stated herein or in written instructions provided by KCI. 

        17.    Inspection.    Upon one week written notice, KCI shall have the right to inspect all facilities used to
manufacture the Products by or for Avail and to inspect all documents and records relating to the manufacture and shipment of the Products. Either party may request a discussion with the other party
concerning any quality control procedures or concerns relating to the Products. The Parties shall implement any reasonable comments and recommendations that are mutually agreed upon. 

        18.    Returns.    KCI and Avail agree to cooperate in good faith to establish adequate procedures for processing and
evaluating returns in a mutually beneficial manner. Avail agrees to incur all freight and return expenses for Products returned due to failure to conform with the terms of this Agreement, the Product
specifications or any KCI purchase order. 

        19.    Excessive Returns.    Customer returns related to failure to meet specifications are considered a quality issue
for the purposes of this Agreement and will therefore be managed consistent with Sections 15 and 23 of this Agreement 

        20.    Term and Termination or Conversion.    The term of this Agreement shall commence on the Effective Date (set out
above), and is effective for a period of thirty-six months thereafter (the "Initial Term"). [***] Either Party may terminate this Agreement, without cause, upon
providing twenty-four months written notice effective as of the next anniversary of the Effective Date following transmittal of such notice to the other Party (a "Voluntary Notice of
Termination"). In addition, KCI may terminate or convert this Agreement to a non-exclusive agreement at its sole option, in the event that Avail: (i) materially breaches this
Agreement, (ii) seeks protection from its creditors under the Bankruptcy or Insolvency Laws of the Federal Government or any State or becomes involuntarily subject to the jurisdiction of a U.S.
Bankruptcy Court or the Court of any State under the Bankruptcy or Insolvency Laws of the Federal Government or any State; (iii) fails in a material way to manufacture Products in accordance
with the Quality Systems Regulations of the Food and Drug Administration and in accordance with any and all applicable international regulations or standards and fails to cure or remedy such situation
within ninety (90) days unless the US FDA, or similar foreign counterpart, require action that takes longer than ninety (90) days to execute, in which case Avail shall have the time
necessary to comply with such regulations or standards; (iv) failure to achieve fulfillment capabilities in Europe by June 30, 2003; (v) manufacture and or distribution of any
Product involved in 

6

 

a
Class I "recall" subject to the conditions specified in sections 15 and 23 and as defined in the regulations promulgated by the Food and Drug Administration (an "Event of Default") and
(vi) failure to meet Product shipping or inventory level standards in accordance with Section 9, or Product quality standards in accordance with Section 15. In addition, Avail may
terminate this Agreement in the event that KCI (i) materially breaches this Agreement or (ii) seeks protection from its creditors under the Bankruptcy or Insolvency Laws of the Federal
Government or any State or becomes involuntarily subject to the jurisdiction of a U.S. Bankruptcy Court or the Court of any State under the Bankruptcy or Insolvency Laws of the Federal Government or
any State. Each of the items with respect to Avail in (i) through (vi) above and with respect to KCI in (i) and (ii) above shall be called an "Event of Default". Either
Party may elect to convert or terminate this Agreement if the other Party is not able to cure an Event of Default within thirty (30) days of written notice of such an Event of Default. In the
event of termination or conversion of this Agreement, Avail shall supply Products to KCI at the pricing in effect as of conversion or termination for a period of one (1) year after any
conversion or termination of this Agreement (subject to price changes permitted in this Agreement), and Avail shall make available to KCI a list of vendors who supply Product components, and to do
such things, as may be reasonably requested by KCI to enable KCI to manufacture the Products in the same manner as previously manufactured by Avail. For purposes of this Agreement, the terms
"conversion" and "convert" shall mean the conversion of this Agreement to a non-exclusive agreement. In the event of termination, KCI agrees to purchase from Avail all finished Product
produced, acquired or committed in accordance with outstanding purchase orders and forecasts, and raw materials in an amount required to produce Products for an additional 60 days at cost plus
a 10% handling fee. 

        21.    Cooperation.    The parties to this Agreement understand that the purposes of this Agreement and the underlying
relationship are to provide certainty of supply and reduce Product cost to assure that the VAC products maintain economic viability in a changing market, while ensuring continued high standards of
quality and service. The success of the relationship toward these ends will depend upon close cooperation between the parties regarding market demand and design enhancements. The parties anticipate
that cooperation and opportunism will yield price improvements on an on-going basis. The Parties will split cost reductions arising from this cooperation on a 50/50 basis with the
following exceptions: i) any price reduction obtained on P/N M3248406 (Drape) will be passed in full to KCI; and ii) any cost reduction requiring capital expenditure of over
$[***] will be retained by the party making the capital expenditure, with KCI having the first right to do so. Election by KCI of its first right under this provision must
occur within 30 days of such capital equipment purchase opportunity being defined by a project cost and benefit analysis or the right to purchase such capital equipment, with all included
benefits, will become Avail's. The parties will work together in good faith to agree upon such other terms and conditions as may be appropriate to achieve each of these purposes and objectives. The
Parties expect and understand that such cooperation shall entail conferences among the principal representatives of the Parties at least semiannually. As part of the ongoing cooperation of the
parties, KCI shall retain the right to approve all suppliers of material to Avail for use in Products and no change of any current supplier, including [***], shall occur
without KCI's approval, which shall not be unreasonably withheld. 

        KCI
represents and warrants that it has no knowledge of any fact, set of facts or circumstances, which have or could result in a default by Avail pursuant to this Agreement. The parties
hereto agree that if any fact, set of facts or circumstances which existed as of the date of this Agreement related to the regulation of the Products and which would otherwise have resulted in a
default under this Agreement become known subsequent to the date of this Agreement that such fact, set of facts of circumstances shall not be deemed to be a default pursuant to the terms of this
Agreement and the parties shall in good faith work to resolve these items. 

        22.    Risk of Loss; Transfer of Title.    Risk of loss and title for any ordered Products shall pass from Avail to
KCI upon Avail's delivery of such items pursuant to the terms of the order. 

7

 

        23.    Warranty.    Avail warrants to KCI that the Products shall be manufactured and packaged in accordance with the
specifications in KCI's master device record for the Products and otherwise agreed by the Parties and that the Products and related packaging shall be of consistent good quality, free from defects in
materials and workmanship. Avail further warrants that all customer-supplied documentation shall be promptly filed in Avail's master device record for each Product. This warranty does not apply to
damage caused by unreasonable neglect, destruction, improper use and improper care. Avail warrants that all Products distributed in the U.S. shall be manufactured in accordance with the Quality
Systems Regulations ("QSR") of the U.S. Food and Drug Administration (hereinafter "FDA"), or any new or revised standards imposed by that agency, in a facility that is registered with the FDA. Avail
warrants that all Products distributed in a country other than the U.S. shall be manufactured and distributed in accordance with all laws, rules and regulations which are applicable to the manufacture
or distribution of the Products in that locale and that such Products shall be manufactured in a facility which is operated in accordance with all laws, rules and regulations applicable to a facility
utilized to manufacture such Products in that locale. Avail warrants that the articles comprising each shipment or other delivery hereafter made by Avail to, or to the order of, KCI's Affiliates or
their respective customers, as of the date of such shipment or delivery, shall not be adulterated or misbranded within the meaning of the Federal Food, Drug, and Cosmetic Act (the "Act"), or any other
applicable law, rule or regulation (including applicable foreign laws, rules and regulations). Avail shall cooperate with KCI to aid KCI in communicating with or otherwise contacting each customer
with respect to the safety or efficacy of the Products as requested by KCI or required by the FDA or any other governmental entity with appropriate jurisdiction. Each of the Parties shall report to
the other any problems relating to the safety or efficacy of the Products as soon as possible after learning of the existence of such problems. Avail shall abide by all regulations of the FDA
applicable to manufacturers of medical devices, including QSR paragraph 820.198 regarding complaint handling and all applicable laws and regulations of foreign countries in which it
manufactures or distributes Products. KCI shall be responsible for compliance with QSR paragraph 820.198 regarding complaint handling. 

        The
design specifications, master records and technical files, as well as all performance and suitability claims for each of the products are the responsibility of KCI. Avail's
responsibility is to accurately convert the aforesaid data into the documents and processes needed to produce the Products. Any failure of the products to meet regulatory requirements or to be
consistently manufacturable based upon the design specifications, master records and technical files is the sole responsibility of KCI. Any recall of any product that is a consequence of an error in
any design specifications, master record, technical file produced by KCI is the responsibility of KCI. Obtaining and maintaining all applicable regulatory approvals and continued compliance for all
products in all jurisdictions served by KCI or any of its affiliates shall be the responsibly of KCI. KCI shall indemnify and hold Avail harmless from any cost or expense directly related to
i) an error in any design specification, master record, technical file or ii) a breach of this agreement. Avail shall indemnify and hold KCI harmless from any cost or expense directly
related to i) a breach of a warranty set forth in, or provided for, in this agreement, and ii) any breach of this Agreement. 

        24.    Force Majeure.    In the event any delay in performance by either party is due to any cause arising from or
attributable to acts, events, omissions, accidents or Acts of God, beyond the reasonable control of the party (including but not limited to strikes, lock-outs, civil commotion, riots, war,
fire, explosion, storm, flood or earthquakes), the party so delayed or prevented shall be under no liability for loss or injury suffered by the other party thereby. In the event that Avail is
prevented from meeting the delivery schedule provided by KCI because of a delay caused by any of such acts, Avail shall give KCI written notification of any material or indefinite delay due to such
causes. In such an event, KCI may not exercise the remedy set forth in Section 9 hereof, but shall (a) instruct Avail that the sales orders affected by such delay are either
(i) affirmed, and the time for performance is extended for as 

8

 

many
days as such causes affect deliveries, or (ii) terminated and (b) have the right to access Product from sources other than Avail with respect to those sales orders. 

        25.    Insurance.    Each party shall carry and continue in force a policy of broad form Products liability insurance
for the Products sold hereunder with limits of not less than $[***] per occurrence and $[***] in the aggregate. All such policies shall provide that
each party shall receive written notice from the insurer thirty (30) days prior to any cancellation or change in coverage of the policy of the other party. Each party shall provide the other
with appropriate certificates of insurance evidencing such coverage. 

        26.    Compliance with Law and ISO Standards.    Avail agrees to comply at all times with all U.S. and foreign
federal, state, and local laws, rules, and regulations relating to the Products during the period of this Agreement. Avail further agrees to comply with standards imposed by the International
Standards Organization and related product development process requirements adopted by KCI. Avail shall tender any documents required by KCI with respect to ISO certification and/or compliance with
laws, regulations and the like. 

        27.    Power and Authority.    Each of the Parties represents and warrants to the other that: (a) it is a legal
entity duly formed and validly existing under applicable law; (b) it has full right, power and authority to enter into and perform its respective obligations under this Agreement;
(c) this Agreement, and its performance hereunder, does not conflict with any outstanding contract, commitment, or arrangement to which it is a party or is bound; and (d) this Agreement
constitutes a legal, valid and binding obligation of such Party. 

        28.    No Liens.    Avail represents, warrants, and covenants that the Products shall be free and clear of all liens
and encumbrances of any kind (collectively, "Liens") at the time of delivery of the Products to the KCI Affiliate or its customer, whichever occurs first. 

        29.    Indemnity.    Avail shall defend, indemnify and hold harmless each of the KCI Affiliates and their respective
directors, officers, shareholders, customers, employees, and agents, and their respective successors and assigns, from and against any and all losses, damages, costs and expenses (including attorney
fees) arising out of any and all claims related to any of the following: (i) the failure of Products to meet specifications, (ii) claims that relate to actual or alleged Liens,
(iii) a breach of this Agreement and (iv) Avail's actual or alleged willful acts or omissions, or gross negligence ("Avail Fault"). Except in the event and to the extent caused by Avail
Fault, and except in the event and to the extent the Products fail to meet specifications set forth herein, as a result of a breach of this Agreement by Avail, the KCI Affiliates shall defend,
indemnify and hold harmless Avail, its directors, officers, shareholders, customers, employees and agents, and its successors and assigns, from and against any and all losses, damages, costs and
expenses (including attorneys' fees) arising out of claims based upon the following, (i) any use, distribution or sale of the Products by any third party resulting in an infringement, or
alleged infringement of any copyright, trade secret, trademark, patent, invention, proprietary information, non-disclosure right or other statutory or common law right of any person or
entity (ii) the failure of the Products design to comply with applicable laws or regulations, including without limitation, those promulgated by the FDA, (iii) any error in any design
specification, master record, or technical file, (iv) any Products liability or other related claims not related to the manufacture of the Products, and (v) a material breach of this
Agreement. Except with respect to the matters set forth in this Section 29, in no event shall either party be liable for any indirect, special, incidental or consequential damages (including,
without limitation, loss of profits, loss of goodwill, interruption of business or other economic loss) whether such damages are alleged as a result of tortuous conduct or breach of contract or
otherwise even if the other Party has been advised of the possibility of such damages. Each of the Parties shall also indemnify, defend and hold harmless the other Party and their respective
directors, officers, shareholders, customers, employees, and agents, and their respective successors and assigns, from and against any and all losses, damages, costs and 

9

 

expenses
(including attorney fees) arising out of any and all claims related to breach of any warranty, representation or covenant of this Agreement. 

        30.    No Infringement.    KCI represents, warrants and covenants to Avail that the Products do not infringe upon or
otherwise violate any valid copyright, trade secret, trademark, patent, invention, proprietary information, non-disclosure right, or other statutory or common law right of any person or
entity. 

        31.    Assumption of Obligations and Liabilities.    The KCI Affiliates do not assume any obligations or liabilities
of Avail. 

        32.    Assignment.    This Agreement shall be binding upon, and shall inure to the benefit of, the Parties and such
KCI Affiliates as may order Products hereunder, and their respective permitted successors and assigns. No assignment or transfer by either party hereto of its rights and obligations hereunder shall be
valid except on prior written consent (which shall not be unreasonably withheld or delayed) of the other party. At KCI's option, in the event of an attempted assignment by Avail to any third party
which KCI considers to be a competitor of any KCI Affiliate, KCI may withhold such consent at KCI's sole discretion. 

        33.    Waiver.    The failure of any party to this Agreement at any time or times to require the performance of any
provisions of this Agreement shall in no manner affect the right to enforce such provision. No waiver by any party to this Agreement, whether by conduct or otherwise, in any one or more instances,
shall be deemed or construed either as a further or continuing waiver of any such provision or breach or as a waiver of any other provision (or of a breach of any other provision) of this Agreement. 

        34.    Notices.    All notices permitted or required hereunder shall be deemed sent when deposited in the U.S. mail,
registered or certified mail, addressed to the parties at each of the following addresses or such other address as a party may designate in writing: 

	If to KCI:	 	If to Avail:
	

Kinetic Concepts, Inc.

Vantage Drive

San Antonio, Texas 78230

Attention: Mike Burke

Vice President, Manufacturing

Re: V.A.C. Disposables	
 	

Avail Medical Products, Inc. Inc.

201 Main Street, Suite 1660

Ft. Worth, TX 76102

Attention: Randy Keene

        35.    Severability.    The invalidity or unenforceability of any term or provision of this Agreement shall not affect
the validity or enforceability of this Agreement as a whole or of any other term or provision hereof. In lieu of any such invalid or unenforceable term or provision, the parties hereto shall negotiate
in good faith to replace the invalid clause or clauses with provisions having similar business purposes. 

        36.    Entire Agreement.    The terms and conditions contained herein and in the attachments hereto constitute the
entire agreement between the Parties and shall supersede all communications, representations, or agreements, either oral or written, between the Parties with respect to the subject matter hereof,
including that certain Manufacturing Agreement dated September 21, 1999. No agreement or understanding varying the terms and conditions hereof shall be binding on either party hereto unless in
writing and signed by duly authorized representatives of each party. Exhibit "A" is incorporated in this Agreement as though set forth herein in its entirety. The terms expressed in Exhibit "A" may be
expanded or otherwise modified in writing upon mutual agreement signed by each of the parties to be bound. Any preprinted terms on preprinted purchase orders shall supplement the terms of this
Agreement only to the extent such preprinted terms are consistent with the terms of this 

10

 

Agreement.
In the event any such preprinted terms are contradictory, the terms of this Agreement shall control (absent written agreement signed by each of the Parties). 

        37.    Applicable Law.    This Agreement shall be governed by and construed in accordance with the laws of the State
of Texas without regard to its conflict of laws provisions, except where a dispute only concerns manufacturing issues, in which case the applicable law shall be California law. The parties hereto
hereby agree that the sole and exclusive place of personal jurisdiction and venue for resolution of any disputes arising hereunder or related hereto shall be the applicable federal courts located in
San Antonio, Texas. 

        If
a dispute arises between the Parties relating to this Agreement, the Parties shall resolve the dispute using binding arbitration, which shall include, without limitation, the
following steps: 

	a)
	The
aggrieved party shall provide the other party with a written request to arbitrate along with written notice of the dispute, which shall identify the nature of the dispute and its
relevant facts;

	(b)
	The
other party shall respond to the notice of the dispute within thirty (30) days after receipt and assert counterclaims, if any, against the aggrieved party;

	(c)
	The
parties shall attempt to agree on the selection of an arbitrator;

	(d)
	If
the parties cannot agree upon an arbitrator, one will be selected pursuant to the Commercial Arbitration Rules of the American Arbitration Association;

	(e)
	The
costs associated with the selection of an arbitrator will be borne equally by both parties;

	(f)
	The
decision of the arbitrator shall be final and binding;

	(g)
	The
arbitrator may award reasonable attorney fees and costs; and

	(h)
	These
procedures and this underlying agreement shall be governed by the common law of Texas without regard to its conflict of laws provisions. 

        38.    Confidentiality.    Each party shall maintain in confidence any trade secrets or proprietary information
disclosed to it by the other party or the other party's agents or representatives, including information disclosed prior to the execution of this Agreement. This information shall include, but not be
limited to, Product information, trade secrets, customer lists and any other confidential business information pertaining to or in connection with the business of the parties. This provision shall
survive the termination of this Agreement. 

        All
confidential information of any of the Avail Parties or the KCI Parties provided to an opposite Party in conjunction with this Agreement or under the Confidentiality Agreement,
whether prior to or subsequent to the execution of this Agreement, will be considered to be information which is confidential and proprietary when (i) it pertains to identification of the
customers of the providing Party or its Affiliates, or (ii) when it was provided prior to the execution of this Agreement and is subject to confidentiality obligations of the Confidentiality
Agreement, or (iii) when the information is provided after the execution of this Agreement and is marked in writing as "CONFIDENTIAL". Such information will hereinafter be
referred to as "Confidential and Proprietary Information," and will be held in confidence, and will not be disclosed to third parties or used for any purpose other than to fulfill the obligations of
this Agreement without prior written consent of the providing Party. Confidential and Proprietary Information will not include information that: 

	(a)
	is
or becomes publicly available through no act or fault of the receiving Party;

	(b)
	is
disclosed to the receiving Party by a third party having the right to disclose it; 

11

 

	(c)
	is
already known by the receiving Party as shown by its prior written records provided the receiving Party provides written notice to the providing Party thereof promptly after
receiving the Confidential and Proprietary Information; or

	(d)
	is
required by law to be disclosed. 

        All
obligations of confidentiality and non-disclosure set forth in this Agreement will survive for a period of three years following the expiration or termination of this
Agreement. 

        39.    Parties Benefited.    This Agreement will be binding and inure to the benefit of the Parties and the KCI
Affiliates, and permitted successors and assigns. The representations, warranties, covenants, and undertakings contained in this Agreement are for the sole benefit of the parties hereto and their
permitted successors and assigns and such representations, warranties, covenants, and undertakings will not be construed as conferring any rights on any other party. This Agreement may not be assigned
by a Party to a non-Party without the prior written consent of the other Parties. 

        40.    No Agency.    Nothing contained in this Agreement will be deemed to place the Parties in a partnership, joint
venture or agency relationship and no party will have the right or authority to obligate or bind any of the other parties in any manner. 

        41.    Multiple Counterparts.    This Agreement may be executed by facsimile signature in two or more counterparts,
each of which will be deemed an original, but all of which taken together will constitute one and the same instrument. 

        42.    Headings.    Paragraph headings have been used in this Agreement but shall not affect the meaning of any
provision of this Agreement. 

        IN
WITNESS WHEREOF, the parties hereto have duly executed this Agreement effective as of the Effective Date first above written. 

	KINETIC CONCEPTS, INC.	 	AVAIL MEDICAL PRODUCTS, INC.
	

By:	

/s/ Michael J. Burke
	
 	

By:	

/s/ J. Randall Keene

	

Name:	

Michael J. Burke
	
 	

Name:	

J. Randall Keene

	

Title:	

V.P. Mfg
	
 	

Title:	

President

	

Date:	

12/18/02
	
 	

Date:	

12/18/02

(Signed Copy on File)  

12

QuickLinks

Exhibit 10.28

AVAIL MEDICAL PRODUCTS, INC. & KINETIC CONCEPTS, INC. AMENDED AND RESTATED MANUFACTURING AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]